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 Rabies is a zoonotic disease that causes every year death of 61 000 humans in the 
world, mainly in Asia and Africa. Dog is the main vector of human rabies. Rabies is a 
preventable disease. Good dog population management program and regular mass vaccination 
campaigns have contributed substantially to the elimination of rabies in dog and humans in 
developed countries. In contrast, rabies remains endemic in majority of resource-poor or 
developing countries such as the Democratic Republic of the Congo (DRC). This thesis aimed 
at assessing factors of dog rabies maintenance in Kinshasa (capital of DRC) and at proposing 
an integrated, efficient and sustainable theoretical rabies control system which is appropriated 
for resource-poor countries. 
Material and methods 
 Kinshasa, the capital of DRC was selected as the study area. It is the largest city of the 
country and its population almost equals 11 million people who are potentially exposed to risk 
of rabies infection. The research was carried out mainly in three peri-urban communes of 
Mont-Ngafula, Ngaliema Lemba where most confirmed dog rabies have been reported. A dog 
ecology survey was conducted in 22 study sites (quartiers) for assessing dog density, dog-
keeping practices and rabies vaccination coverage as risk factors of rabies maintenance and 
establishment of low scale risk maps. It was completed by GPS tracking of a subgroup of 
owned dogs (n=16) for the characterization of dog  roaming behaviour, the street-count for 
estimation of proportion of feral dogs and  the serological evaluation of the immunization 
status of a subgroup of 132 reported vaccinated dogs (study 1). Thereafter, a risk-based 
vaccination scheme was developed by considering the canine population dynamics in settings 
with low risk and high risk for rabies transmission and by considering field serology data 
regarding efficacy of vaccination and duration of immunity (study 2). Finally, the stakeholder 
analysis method was used for the description of existing rabies surveillance and control 
networks in DRC (study 3). It aimed to assess the level of collaboration between them for the 
efficient control of rabies and to identify in as far as the existing surveillance system might 
implement the control strategy that emerged from studies 1 and 2.  






 Study 1 found that the poor dog-keeping practices and the low vaccination coverage 
were the main risk factors of rabies maintenance in dog population. Between 2 to 100% 
(mean 60%) of owned dogs were intermittently or continuously free roaming. The absence of 
a physical barrier appeared as the major reason of the poor restriction of dog movement. 
However, due probably to poverty, some owners allowed dogs to roam in search of food. 
Furthermore, irrespective of time since last vaccination, the coverage significantly differed 
between study sites and ranged from 24 to 81% (mean 56%), whereas the coverage of 40% is 
the critical threshold under which large rabies outbreaks may occur. Yet, owners’ compliance 
towards mandatory vaccination strongly depended on their socio-economic situation and the 
subsequent ability to afford vaccination costs. Low vaccination coverage (40%) occurred 
almost in areas with low proportions of restricted dogs. The percentage of feral dogs was low 
(≤2%). The combination of the three main risk factors including dog density, roaming activity 
and vaccination coverage in form of a risk map reflected the likelihood of rabies transmission 
at the level of quartiers. This risk was found to be high, medium and low respectively in 41% 
(9/22) and 32% (7/22) and 27% (6/22) of study sites.  
 Study 2 based on canine population dynamics and field serology evidenced the link 
between the dog-keeping practices and the turnover rate. The annual turnover rate was 36% in 
settings with high proportion (≥75%) of free-roaming dogs, whereas it was 17% in settings 
with low proportion (25%) of free-roaming dogs. The assessment of vaccine efficacy in 
terms of serological response to primary or booster vaccination under the field conditions 
revealed that the efficacy was similar (p=0.24) in puppies (2-3 months: 96%), juvenile (3-12 
months: 97%) and adult dogs (>12 months: 100%). By assessing the anamnestic response to 
booster vaccination, field data provided evidence for a protection of at least 3 years. Thus, 
given the short life expectancy (≤3 years) of 75% of surveyed dogs, it was hypothesized that 
vaccine may provide a lifetime protection against rabies for the majority of the investigated 
dog population. Furthermore, the study found that the systematic vaccination of puppies at 3 
months of age was preventing the decrease of the vaccination coverage even in settings with 
high turnover rate (36%).  
 Study 3 showed that institutions of wildlife sectors are not included in rabies network, 
mainly because of the lack of surveillance system of wildlife diseases such as rabies. The 




the collaboration between medical and veterinary sectors was inadequate (weak), 
notwithstanding the existence of human and animal disease surveillance systems and the 
countrywide implantation of medical and veterinary institutions. Resources and data are not 
shared between both sectors either because they are not available or due to lack of legal 
collaborative framework. 
  
 Key findings of above-mentioned studies that are necessary for development of a 
theoretical framework for improving the efficiency of rabies control in resource-poor settings 
can be summarized as follows: 
 The stratification into risk zones of rabies transmission should allow  optimization 
of resource allocation by initially targeting high risk zone;  
 The systematic vaccination of puppies at weaning (≥8 weeks of age) is 
recommended. It appears as an efficient and cheap method in comparison to annual 
vaccination of all accessible dogs irrespective of their vaccination status; 
 The existing rabies network composed mainly of medical and veterinary structures 
is an asset for implementing the control strategy that emerged from this research 
provided that the collaboration between those structures is effective at the 
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1.1. General introduction  
1.1.1. Overview on rabies in DRC 
 Rabies is an acute meningo-encephalitis caused by a virus of the genus Lyssavirus . Its 
existence backs to the antiquity period over which the disease was generally associated with 
bite by “mad dogs” or “raging dogs”. All mammals including human are susceptible to rabies, 
therefore making rabies one of the oldest zoonotic disease (Steele, 1975; Neville, 2004).  It 
was estimated in 2010 that rabies is responsible for more than 60,000 annual human deaths 
across the world, predominantly in Asia and Africa (WHO, 2013).  
 In Africa, rabies outbreak was reported for the first time in Algeria in 1858 (Steele, 
1975). To date, rabies remains a public health threat that kills around 23 800 human per year, 
mainly through bites of dogs (Knobel et al., 2005; WHO, 2013). However, it should be 
underlined that this burden of rabies in Africa is an estimate determined in 2010 on the basis 
of probabilistic methods such as the probability decision- tree approach. Such estimates lack 
accuracy and need rabies field data for validation (WHO, 2013). In Democratic Republic of 
the Congo (DRC), rabies was confirmed for the first time in dog and human in 1923 and 
1935, respectively (Repetto, 1932; Chesterman and Liégois, 1937). According to published 
and unpublished laboratory data, more than 1400 dog rabies cases and 2 jackal rabies cases 
were confirmed across the country by the three national veterinary laboratories in Kisangani, 
Lubumbashi and Kinshasa, from 1939 to 2017 (Courtois et al., 1964; Makumbu, 1977; Bula 
and Mafwala, 1988; Twabela et al., 2016). Nowadays, the dog seems to be the main vector of 
rabies in DRC, given the close physical and spatial relationship between dogs and people. In 
Kinshasa, about 9% of households owned at least one dog ( Kazadi et al.,2020). A similar 
proportion (10%) of dog-owning households was reported in Matadi, the capital of the 
Province of Kongo Central (Mbilo et al., 2019). The dog is usually given in the hands of 
young people who daily take care of him (feeding, cleaning) and which could be considered 
as the true dog owner rather than the chief of family (personal observation). Leftovers from 
human consumption are the main source of dog food. Few dogs receive proper housing, 
husbandry and veterinary care. As is the case in many sub-Saharan African countries, the 
great importance of owning a dog is given to sociocultural and economic purposes rather than 
companionship purpose. Accordingly, the dog is kept for guarding, hunting, meat 
consumption and mystical protection (Makumbu, 1977, Akakpo, 1985, Kazadi et al., 2017, 




 In DRC, since 1923, large and small rabies outbreaks often occur throughout the 
country, but they are usually not documented. The only documented rabies outbreak occurred 
in 2009 during which more than 70 people died. Most of victims were children of less than 15 
years who were bitten by rabid dogs, and Kinshasa (the capital of DRC) was the most affected 
city during this outbreak accounting for more than 70% (52/70) of human deaths (Muyila et 
al., 2014). Beside this outbreak, from 2003 to 2017, 11,098 human exposures, 27 confirmed 
canine cases and 154 human clinical rabies cases occurred in Kinshasa (Twabela 2016, 
unpublished data). Most confirmed dog rabies cases were reported in peri-urban Communes of 
Mont-Ngafula, Ngaliema and Lemba (Fig 1.1). Yet, Kinshasa is a megalopolis that has a 
population almost equals 11 million people (INS, 2017), who are potentially exposed to dog 
bites and rabies. By looking at these official data about bite victims and suspect rabies cases, 
it is very likely that they are under-reported as in many endemic countries such Tanzania, 
Ethiopia and Bhutan (Cleaveland et al. 2002; Kitala et al., 2002; Hampson et al., 2008; Deresa 
et al., 2010; Tenzin et al., 2011; Jemberu et al., 2013). It appears that the inefficient 
surveillance system, poor veterinary infrastructures and limited diagnostic capacity of national 
veterinary laboratories are the main reasons of underreporting level of animal disease data in 
DRC (Niang and Denormandie, 2008; Diop et al., 2012; Ministère de la Pêche et de 
l’Elevage, 2017). In particular, given that rabies is a zoonotic disease, further investigation 
need to be carried out to evaluate the interaction between institutions or sectors which are 
assumed to be involved in rabies management in DRC for identifying reasons of data 
underreporting. 
 Consequently, the true disease burden is obscured for the above-mentioned reasons, 
while rabies continues to kill dog and humans mostly in poor communities. In addition, 
despite the existence of laws regarding the regulation of dog rabies control such as the control 
of dog movement (Royal Decree of 05 May 1936) and the mandatory vaccination of dogs 
against rabies (Royal Decree of 01 April 1938), rabies is still maintained in dogs, which in 
turn infect humans mainly through bites. Therefore, the assessment of factors of dog rabies 
maintenance, the development of a risk-based vaccination scheme and the assessment of the 







Figure 1.1. Map of the positive dog rabies cases recorded in municipalities of Kinshasa from 
2003 to 2017 
1.1.2. Thesis objectives 
a. General objective  
 This thesis aimed at assessing factors of dog rabies maintenance in Kinshasa and at 
proposing an integrated, efficient and sustainable theoretical rabies control program. 
b. Specific objectives 
Four specific objectives were defined to achieve the main objective as follows: 
1. To investigate the risk factors involved in rabies transmission between dogs and to 
establish a risk map of rabies transmission based on identified risk factors; 
2. To develop a risk-based vaccination strategy for rabies control in dog population;  
3. To describe the rabies network and to assess the level of interaction between 
stakeholders; 








1.1.3. Thesis outline  
 
 The present manuscript contains six chapters. Chapter 1 provides the overview on 
rabies in DRC, the general and specific objectives of thesis and the literature review on rabies 
by emphasizing on general measures for dog rabies control.  Chapter 2 is related to the first 
specific objective of this thesis. It identifies the main risk factors of rabies maintenance in dog 
population in Kinshasa, from which rabies transmission risk zones were established using a 
developed tool for stratification of risk zones. Chapter 3 corresponds to the second specific 
objective of this thesis. This chapter explores the risk-based vaccination strategies in 
connection with the established rabies risk zones, the dog population parameters (age 
structure, turnover rate) and the vaccine characteristics (success rate in puppies, duration of 
immunity). Chapter 4 is related to the third specific objective. It describes the existing rabies 
network in DRC and assesses the level of interaction between stakeholders or institutions.  
Chapter 5 summarizes and discusses the key findings obtained from chapters 2, 3 and 4. It 
focuses on improving dog rabies control in resource-poor settings by suggesting a theoretical 
control framework.  Finally, the Chapter 6 corresponds to conclusion and perspectives. 
1.2. Literature review 
1.2.1. History of rabies  
 Rabies is an ancient disease that backs to antiquity. Human rabies was earlier 
referenced than dog rabies. The first human rabies case was reported in Egypt and in ancient 
Greece around 2300 BC, whereas the first canine rabies was described some 500 years BC by 
Democritus. The saliva from infected dogs was recognised as infective material in 1804 by 
Zinke. In 1881, Pasteur demonstrated the neurotropism of rabies virus in rabbits and few 
years later more precisely in 1885, in collaboration with Chamberland and Roux; he 
discovered the first rabies vaccine which was administered the same year to Joseph Meister, a 
child aged of 9 years who was attacked by a rabid dog (Steel, 1975; Blancou, 2003). 
 Despite the discovery of vaccine, the causative agent of rabies was not yet well 
understood. In 1903, Negri identified inclusion bodies in the brain tissue of rabid dog and 
humans. He observed that those inclusions bodies were plentiful in the horn of Ammon. He 
strongly believed that they were the causative agent of rabies and belonged to parasitic 
protozoan class. In 1927, Sellers developed a useful and widely used method of demonstrating 




and Dawson developed the mouse inoculation test that was the big advance in rabies 
diagnosis. The rabies virus was observed for the first time on the electronic microscope in 
1960. Its structure was completely elucidated 25 years later thanks to molecular biology 
(Steel, 1975; Bourhy et al., 1993). 
 As mentioned above, rabies outbreaks were reported since antiquity (Steele, 1975; 
Neville, 2004). In the DRC, the first dog rabies outbreak was documented in 1923 with 
laboratory confirmation of rabies in two dogs in Boma city, located in the actual Province of 
Kongo Central (Repetto, 1932). Then, in 1935, rabies was confirmed for the first time in 
human, a woman who was bitten by a mad dog in Yakusu, located in the actual Province of 
Tshopo (Chesterman & Liégois, 1937). The first anatomical pathology laboratory for rabies 
diagnosis was developed in 1939 by Liégois and was hosted at the veterinary laboratory of 
Stanleyville (Kisangani) (Courtois et al., 1964). In 1950, dog rabies was officially declared 
enzootic by national authorities (decree 54/341, 28 September). 
1.2.2. Rabies virus 
 The rabies virus is a bullet shaped enveloped infectious particle (180 nm x 75 nm in 
size), with a 12 Kb negative sense single-stranded RNA genome and belongs to the genus 
Lyssavirus of the family Rhabdoviridae and the order Mononegavirale. It has five structural 
proteins and is surrounded by an envelope in which a glycoprotein (G) is embedded.  Besides 
the G protein, other proteins are nucleoprotein (N), matrix protein (M), non-structural proteins 
(NS) and RNA-dependent RNA polymerase protein (L) (Woldehiwet, 2005; Van Gucht and 
Le Roux , 2010). The virus is very sensitive to some environmental factors and it is therefore 
rapidly destroyed by direct sunlight, desiccation, U.V irradiation, heat, trypsin and common 
detergents (Awoyomi et al., 2007; Leung et al., 2007).  
 Speaking to the function of proteins, the N protein plays critical role in viral 
replication and transcription, as long as it is not phosphorylated (Wu, 2002). The M protein 
forms oligomers that bind to the outside of the nucleocapsid, giving rigidity to the virion 
structure and providing a binding platform for the viral glycoprotein and the envelope 
membrane (WHO, 2013). The G protein is responsible for the induction of protective 
immunity and contains motifs that define virulence and pathogenicity of the virus. Therefore, 
any change of G protein (e.g. amino acids) affects the pathogenicity, antigenicity or 
immunological characteristics of the virus (Cox et al. 1977; Dietzschold et al., 1978; Warrell 




 The genus Lyssavirus is presently composed of 16 species (genotypes) of rabies virus 
(Table 1.1). The classical rabies virus (RABV) and its field strains cause rabies in majority of 
the cases in humans and animals worldwide, except in Australia and several islands where the 
virus has not yet been reported. Accordingly, all currently available human and veterinary 
vaccine strains originate from RABV. The 15 other species are called rabies-related virus, but 
they may also cause a fatal rabies disease in animals and humans. Rabies-related viruses 
which are widely distributed in Africa are Lagos bat virus (LBV), Mokola virus (MOKV) and 
Duvenhage virus (DUVV). Two other rabies-related lyssavirus are country-specific, namely 
Shimoni bat virus (SHIBV) and Ikoma lyssavirus (IKOV) discovered respectively in Kenya 
and in Tanzania. Australian bat lyssavirus (ABL) is limited in Australia and can be 
transmitted from bats to humans and animals. European bat lyssavirus (EBLs 1 and 2) are 
limited to the Western and Eastern Europe. Seven novel rabies-related lyssavirus have been 
recovered from bats in Eurasia. These are Khujand virus (KHUV), Aravan virus (ARAV), 
Bokeloh bat virus (BBLV), Irkut virus (IRRKV), West Caucasian bat virus (IKOV), Lleida 
bat lyssavirus (LLEBV) and Gannoruwa bat lyssavirus (GBLV) (Marston et al., 2012; WHO, 
2013, Aréchiga Ceballos et al., 2013; Fisher et al., 2018). 
 Lyssavirus species are grouped into two distinct phylogenetic groups (phylogroups) 
and one unclassified group based on serum cross-reactivity against the viral proteins and 
thresholds in genetic sequence differences (WHO, 2013, Fisher et al., 2018). It is worth noting 
that the current vaccine strains are originated from the classical rabies virus (RABV), which 
in turn belongs to phylogroup 1. Laboratory experimental studies reported that besides rabies 
infection caused by classical rabies virus, the vaccine was poorly effective against infection 
caused by other rabies species of phylogroup 1 such as Duvenhage virus (Tignor et al., 1977) 
and European bat lyssaviruses type 1 (Fekadu et al., 1988; Lafon et al., 1988). In addition, the 
vaccine was ineffective against infection caused by rabies species of phylogroup 2 and 
unclassified phylogroup (Koprowski et al., 1985; WHO, 2013). It is assumed that the poor or 
absence of cross-protection provided by the current vaccines against rabies infection caused 









Table 1.1. Viruses included in the genus Lyssavirus (WHO, 2013; Fisher et al., 2018) 
Phylogroup Species (abbreviation) Primary host Geographical range 
Phylogroup1 Rabies virus (RABV) Carnivora and bats 
(chiroptera) 
Terrestrial mammals 
worldwide except in 
Australia, Antartica, 
and several islands; 
bats in the New 
World only 
Australian bat lyssavirus 
(ABLV) 
bats of Pteroptus genus 
and insectivorous bats 
Saccolaimus albiventris 
Australia 




Europe, from Spain to 
the Ukraine 
European bat lyssavirus, 
type2 (EBL2) 
Insectivorous bats  Myotis 


























Insectivorous bats Sub-Saharan Africa 
Phylogroup2 Lagos bat virus 
(LBV) 






Mokola virus(MOKV) Unknown Sub-Saharan Africa 





Unclassified  West Caucasian bat 
virus(WCBV) 






African civet Civettictis 
civetta 
United Republic of 
Tanzania 





Gannoruwa bat lyssavirus 
(GBLV) 





1.2.3. Mode of transmission  
 Since 1804, saliva from rabid dogs was recognized as infective material. Indeed, from 
the central nervous system of the rabid animal or infected human, the rabies virus reaches the 
salivary gland and is then excreted in saliva, thereby making the bite as the main route of 
rabies infection (Singh et al., 2017). The human-to-human transmission through bite is 
theoretically possible but rare. There is only one report of a 2 year-old boy with encephalitic 
rabies who bit his mother (Feder et al., 2012), recalling the needs to take protective measures 
while caring for an infected patient in order to reduce the risk of infection. In contrast, bite is 
the main route of rabies transmission from animal to animal and from animal to human. In 
Asian and African countries, the dog bite is responsible for 98% of human rabies cases 
(Knobel et al., 2005). In addition, the risk of rabies infection by bite (5%-80%) is high as 
compared to licks or scratches (0.1%–1%) (Hemachudha et al., 2013). 
 Besides the bite, few non-bite exposures were reported in humans. These are : (i) 
aerosol transmission during vaccine production as reported by Winkler et al. (1973) or by 
visiting caves occupied by many bats infected with rabies virus. Although this second way of 
aerosol transmission remains theoretically possible, it has never been well documented in 
natural environment, (Gibbons, 2002); (ii) transplantation of tissue or organ. Although this 
rabies transmission route is  rare, in Germany in 2005, a man was infected through corneal 
transplantation (Hellenbrand et al., 2005); (iii) direct contact of mucosa or fresh skin wounds 
with infectious material such as saliva (Takayama, 2008), (iv) exposures to live vaccines for 
animal workers during vaccination ( Singh et al., 2017); and finally (v) dog slaughtering 
process that includes the catching, handling, loading, holding, transportation, keeping in the 
cages and slaughtering per se. The risk is very high in Asia and Africa where dog meats are 
consumed, despite it was established that eating of dog meat does not cause the disease 
(Garba et al., 2013). 
 1.2.4. Species affected and epidemiological cycles of rabies  
 All mammals including human are susceptible to rabies, but only a limited number act 
as reservoirs of lyssavirus. These are members of the order of Carnivora including domestic 
dogs (Canis lupus), raccoons (Procyon lotor), skunks (Spilogale putorius), foxes (Vulpes 
vulpes), jackals (Canis aureus) and members of the order Chiroptera (bats) (Sedganti and al., 




can cause rabies in other hosts. Usually the variant die in new host (species) to which it is not 
adapted and it can only occasionally establish in a new host (Spickler, 2012). 
  Two main epidemiological rabies cycles are described, namely the urban cycle and the 
sylvatic cycle. The urban rabies cycle is propagated primarily by dogs, predominantly in 
Africa, Asia, the Middle East and Latin America. In these regions of the world, more than 
95% of human cases are caused by bites of rabies-infected dogs. Rural and poor communities 
are the most affected (WHO, 1987, Knobel et al., 2005; Spickler, 2012, Global Alliance for 
Rabies Control, 2015), thereby displaying the contrast with concept of “urban rabies”. 
Although sporadic contamination of dogs by wild animals, the urban rabies cycle has been 
virtually eliminated in the United States of America, Canada and Europe for several decades. 
However, the canine rabies variant is apparently established in some wildlife populations 
(e.g., foxes and skunks in North America) and it can re-establish in dogs from these reservoir 
hosts (WHO, 1987; Spickler, 2012; Fisher et al., 2018) 
 
 The epidemiology of sylvatic rabies cycle is complex given the virus strains, the 
behaviour of the host species, the ecological and environmental factors. After the elimination 
of urban rabies, the sylvatic rabies is the predominant cycle in Europe and North America 
(Spickler, 2012). In Europe, foxes are the main reservoir of rabies since 1950, although the 
growing role of raccoon dogs (Nyctereutes procyonoides) in the rabies epizootiology 
(Vitasek, 2004; Van Gucht and Le Roux, 2010; Fisher et al., 2018). In the North America, 
raccoons stunk and bats are the main wildlife maintenance hosts of rabies. In Latin America, 
besides coyote, vampire and nonhematophagous bats usually attack the humans and are the 
main wildlife vectors of human rabies, whereas jackals and mongooses maintain virus in 
some countries of southern Africa such as Republica of South Africa, Namibia and Zimbabwe 
(WHO, 1987; Dantas-Torres 2008; Spickler, 2012).  
1.2.5. Pathogenesis 
 The pathogenesis of rabies virus is illustrated in Figure 1.2. Indeed, the rabies virus 
enters the subcutaneous and muscles tissues of host through a bite wound. Depending on the 
concentration of the virus inoculated, inoculation site and its density of innervations, the virus 
remains dormant (eclipse period) at the injected site usually during 3 to 8 weeks, rarely as 
short as few days (≤1 week) or as long as several years (Greene and Rupprecht, 2006; 
Heymann, 2008). The incubation or eclipse period is shortened when the bite occurs on the 




rabies quickly. In contrast, prolongation of the incubation period gives a chance for post-
exposure treatment and immunity for clearance rabies virus in the host (Hemachudha et al., 
2002). At the injected site, the virus replicates in muscle tissues and enters the peripheral 
nervous system (PNS) via nicotinic acetylcholine receptors at the neuromuscular junction 
(Lentz et al., 1982) and then travels from peripheral nervous system to central nervous system 
(CNS) through sensory and motor axons via an axonal retrograde transport system at a rate of 
12-100 mm/day (Kucera et al., 1985; Kelly and Strick, 2000). When the virus invades the 
central nervous system, it replicates extensively and causes encephalitis leading to neuronal 
degeneration and clinical disease develops (Kucera et al., 1985). However, partially due to the 
genetics of infecting virus, the fatal invasion of central nervous system might not necessarily 
be accompanied by substantial brain inflammation as seen in some cases of dog rabies 
(Ugolini, 2011). Finally, the virus runs out through the peripheral nerves and invests in most 
other organs, especially salivary glands, skin, mucosal surfaces, and gut. The rabies virus 
causes relatively slow but progressive disease without initial clinical signs which turns into a 









1.2.6. Immunology  
 It is important to note from the outset that in case of infection or vaccination, two 
categories of immunity responses are triggered for fighting against invading pathogens, 
namely, the innate and adaptive immune responses. The innate immune response is not 
pathogen specific and is triggered early, within the first hours following the entry of 
pathogens or vaccine antigen. It involves the release of cytokines, including type 1 interferons 
(IFN-α and -β) and chemokines, the activation of complement and the attraction of 
macrophages, neutrophils and natural killer (NK) cells into infected tissues. In contrast, the 
adaptive (acquired) immune response is very specific to pathogen and requires several days to 
be set up. It has memory that provides a long-term protection and a quick and efficient 
response upon re-infection. However, its activation needs information from the innate 
immune system. Thus, both efficiency of vaccines and defense against pathogens depend 
upon the robustness of the innate immune responses. When activated, the adaptive response 
brings into play the cell-mediated immune response, which is carried out by T cells, and the 
humoral immune response, which is controlled by activated B cells and antibodies (Le Bon 
and Tough, 2002; Lafon, 2007). 
 When the rabies virus enters the host through nasal instillation or a breach in the skin 
and muscles, it triggers an immune response in the periphery before it reaches the nervous 
system. This includes the secretion of cytokines, the appearance of activated lymphocytes and 
production of circulating neutralizing antibodies (Lafon, 2007; Singh et al., 2017). Once the 
rabies virus reaches the nervous system, it escapes the host immune response and protects the 
infected neurons against apoptosis or premature destruction of neurons. Consequently, both 
innate and adaptive immune responses are tardily triggered. Neutralising antibody and 
inflammatory infiltration are usually absent at the time of onset of encephalitic signs. 
Antibody titres reach substantial levels only in the terminal stages of the disease, which is too 
late for survival. Cell-mediated immunity plays little role in a rabies infection due to 
inactivation of T cells by rabies virus ( Lafano, 2007; Hunt, 2012; Fisher et al., 2018).  
 Despite rabies virus escape to immune response, a prompt post-exposure vaccination 
limits the rabies infection mainly when the incubation period is long (Hunt, 2012). The 
vaccine induces a sustained antibody response with the help of CD4 T lymphocyte activation. 
Antibodies can neutralize the rabies virus particles before they reach the neuronal system. 




the central nervous system. In addition, in the central neuronal system, antibodies can clear 
rabies virus particles in the early steps of nerve infection (Lafono, 2007). However, T cells are 
more important for clearance rabies virus from infected tissues than antibodies. Additionally, 
laboratory studies established that rabies virus is a T-cell-dependent antigen (Turner, 1976; 
Mifune et al., 1981). T cells induce neuronal apoptosis and thus can initiate an 
immunopathological reaction for clearance of rabies virus in infected tissues. However, live 
post-exposure vaccines (DNA and recombinant vaccines virus) induce a strong deleterious 
CD8 T cell response in the nervous system, which is clinically associated with paralysis. 
Thus, due to those side effects related to live vaccines, it better to use live vaccines for pre-
exposure vaccination regimens because of the robustness of live immunization. In contrast, 
inactivated post-exposure vaccines that induce mainly B cell activation with the help of CD4 
T cells are the most appropriate choice to preserve integrity of the neuronal system (Lodmell 
and Ewalt, 2001; Lafano, 2007). 
1.2.7. Rabies diagnosis 
a. Anamnesis and clinical signs 
 The incubation period of rabies infection varies widely in humans and animals. In 
most species, the incubation period of natural rabies infection is about 3 weeks but varies 
from 2 weeks to several months. It may be around 10 days to 6 months in dogs and cats. It 
seems shorter in unvaccinated animals than in vaccinated animals. (Hudson et al. 1996a , b; 
Radostits et al., 2007; Spickler, 2012). In humans, the incubation period varies from few days 
to several years. Typically, it is 1–3 months but may vary from less than 1 week to over a year 
(Greene and Rupprecht, 2006). 
 In dogs, the first symptoms of rabies are non-specific and include restlessness, 
anorexia or an increased appetite, vomiting, slight fever, dilation of the pupils, hyper-
reactivity to stimuli, and excessive salivation. Then, the affected dog may become either more 
aggressive or unusually affectionate, opposite to its normal behaviour and temperament. It 
may also turn unresponsive to its owner and may prefer sitting in isolation. This stage is 
called the prodromal phase and usually last for 2–5 days. Once these abnormal behaviours 
occur, the dog shall be isolated (Campbell and Charlton, 1988; Baer, 1991; Spickler, 2012). 
The prodromal phase may lead to further progression of the disease in two clinical forms: 
furious and dumb form. However, the predominance of either clinical forms of rabies is 




source of virus. The virus from vampire bats almost always causes the paralytic form, 
whereas the street virus causes almost the furious form which is most prevalent in dogs 
(Radostits et al. 2007). Dog affected by the furious form of rabies becomes quite excited, 
restless and dangerously aggressive. It bites inanimate objects (own chain, stones, paper, 
wood, and metal) and attacks other animals and humans. It may not recognize its owner and 
may show hallucination signs such as snapping at imaginary objects. There may be unusual 
bark and aimless wandering. Later, there is drooling of saliva due to paralysis of muscles 
implied in swallowing. Partial paralysis of vocal cords leads to change in tone of bark to 
howl. In the terminal stage, there is muscular incoordination and paralysis of limbs and trunk. 
Death occurs within 4 to 8 days after the onset of clinical signs mostly due to respiratory 
paralysis and convulsions (Spickler, 2012). The dumb form is less common in dogs and is 
characterized by progressive paralysis. The excitement phase is short or absent in the dumb 
form. Throat and masseter muscles become paralysed and the animal may be unable to 
swallow. This causes saliva to accumulate with possible drooling and foaming. There may be 
facial paralysis or the lower jaw may drop. The dog has a dull or vacant expression and 
prefers to sit isolated in a corner. It may respond to its owner’s call but there is tendency of 
forgetfulness. Paralysis begins with the muscles of head and neck region. The animal has 
difficulty in swallowing. This is often mistaken as bone stuck in the mouth and the owner out 
of ignorance tries to help the dog and gets exposed to infection. General paralysis results in 
death of the animal usually within 3 to 5 days. However, in dogs, rabies should be 
differentiated from other neurological diseases such canine distemper, canine encephalitis and 
poisoning (Campbell and Charlton, 1988; Baer, 1991).  
 In cats, the furious form is the most common form of rabies. The animal may strike at 
the air with its forepaws as if it were catching mice. Paralysis of the hind part begins within 
2–4 days after the symptoms of excitement, and the animal generally dies in 3–5 days due to 
convulsions and respiratory paralysis (Radostits et al., 2007). 
 In ruminants namely cattle, sheep and goats, rabies should be suspected when there is 
a sudden change in disposition and failure to eat or drink, when the animal becomes paralyzed 
or runs into objects and when it separates from the herd and stops ruminating (Shultz, 2004). 
Rabies in ruminants may be manifested either in furious form or in paralytic form. In an 
experimental study, major clinical findings of the disease included excessive salivation (100 
%); behavioural change (100 %); muzzle tremors (80 %); vocalisation (bellowing 70 %); 




The furious form occurred in 70 % cases. The animal usually dies 4–8 days after the onset of 
the clinical signs (Hudson et al. 1996b; Radostits et al., 2007). 
 In horses, the clinical signs of rabies included abnormal postures, frequent whinnying, 
aggressiveness and kicking, biting, colic, lameness, ataxia, paresis of the hindquarters, 
recumbency, convulsions and terminal paralysis. The furious form occurs in 43 % of cases, 
some of which began as the dumb form. The death occurs within 5 days after the onset of 
clinical signs (Radostits et al. 2007). 
 The clinical findings in pigs are extremely variable and only one or two of the classical 
findings may occur. Pigs manifest excitement and a tendency to attack or dullness and 
incoordination. Affected sows show twitching of the nose, rapid chewing movements, 
excessive salivation, and clonic convulsions. They may walk backwards. There is paralysis in 
terminal stage and death occurs 12–48 h after the onset of signs (Radostits et al., 2007). 
 
 In wild animals, rabies shall be suspected when there is a change in behaviour such as 
loss of fear of man or unusual friendliness. Nocturnal animals may show abnormal activity 
during daytime and may attack humans. In the furious form of rabies, there is unprovoked 
aggression and some animals may attack anything that moves or even inanimate objects. The 
affected animal may appear disoriented or uncoordinated, or wander aimlessly. It may 
stumble or fall. Paralysis often begins in the hind legs or throat. Paralysis of the throat 
muscles can cause the animal to bark, whine, drool, choke, or froth at the mouth. 
Vocalizations ranging from chattering to shrill scream are observed. Terrestrial mammals 
such as skunks, raccoons, and foxes usually display furious rabies. Bats often display dumb 
rabies. They are unable to fly and they may be found on the ground, thereby increasing the 
risk of infection particularly in children, who are more likely to handle wild animals than 
adults (Shultz, 2004). 
 As a reminder, the incubation period of rabies in humans usually ranges between 3 and 
8 weeks and is rarely less than 1 week or over 1 year. The length of the incubation period 
depends on factors such as the amount of virus inoculated the degree of innervation at the site 
of viral entry, and the proximity of the bite to the central nervous system (Greene and 
Rupprecht, 2006; Heymann, 2008). The first signs are non-specific and may include itching, 
pain and paraesthesia at the bite site, headache, anxiety, restlessness, fever and 




system, it causes a progressive fatal encephalomyelitis. Both furious and dumb forms may 
appear, but usually one form predominates. The furious rabies is characterized by irritability, 
agitation, hyperesthesia, hydrophobia aerophobia, photophobia and generalized flaccid 
paralysis. Hydrophobia is considered as the pathognomonic symptom of rabies in humans. 
The affected person shows panic, fear when presented with liquids to drink as a consequence 
of violent spasm of the gullet and painful laryngospasm (Meslin, 2005; Nigg and Walker, 
2009). The furious form of rabies should be differentiated from delirium tremens, botulism, 
diphtheria, drug ingestion (phenothiazines and amphetamines), plant ingestion (Datura 
fastuosa), cerebral malaria, whereas the dumb form of rabies that occurs in 30% of human 
cases, should be differentiated from Guillain-Barre syndrome, polio herpesvirus simiae 
(Leung et al., 2007; Mallewa et al., 2007, WHO, 2013). It is characterised by generalised 
paralysis, it runs a less dramatic and usually longer course than the furious form but it is 
ultimately fatal too (WHO, 2013). 
b. Laboratory-based diagnosis  
 The laboratory-based diagnosis of rabies is usually made after death. Indeed, most 
diagnostic tests for rabies in animals require brain material which is available only after death 
(Fooks et al., 2012). Brain smears or touch impressions are used for the detection of virus 
antigen using the fluorescent antibody test (FAT) or direct fluorescent antibody test (dFAT) 
both for animals and human samples (WHO, 2013, OIE, 2014). Other diagnostic techniques 
include reverse transcription polymerase chain reaction (RT-PCR), direct rapid 
immunohistochemistry test (dRIT) and serological tests such as fluorescent antibody virus 
neutralization test (FAVN) and rapid fluorescent focus inhibition test (RFFIT) (Lembo et al., 
2012; WHO, 2013; OIE, 2014).  
 Serological tests are rarely used in the diagnosis of rabies. They are used primarily to 
assess the immune status of man and other animals such dog, cats following vaccination or for 
assessment of potency of rabies vaccines. They are of limited value in the detection of rabies-
infected animals given that the immune responses following natural infection vary 
considerably, and antibodies may be produced only in the terminal stages (Singh et al., 2017). 
 In humans, above-mentioned diagnostic techniques can be used to confirm a clinical 
case of rabies while the patient is still alive, especially when a history of exposure to an 
animal is lacking or for identification of other people who may have been exposed to the same 




follicles from patients with clinical rabies. However, the intra-vitam diagnosis of rabies in 
animals is discouraged because of great risk of contamination (WHO, 2013).  
1.2.8. Prevention and control of rabies  
 The present section focuses on prevention of rabies in humans and on measures for 
rabies control in dog population, given that 98% of human rabies deaths are caused by dog 
bites in Asia and Africa (Knobel et al., 2005). In addition, even in areas where wildlife 
species are the rabies reservoir, due to its proximity to the humans, the dog provides a link in 
transmission between wildlife and humans (Knobel et al., 2007). 
a. Prevention of rabies in humans  
 Rabies is almost without exception a lethal disease. Once neurological signs occur, the 
lethality reaches 100% in despite of administration of post-exposure prophylaxis. Thus, it is 
important to prevent rabies before and after suspected or proven exposure to virus by 
immunization. The pre-exposure prophylaxis is strongly recommended for people, who are at 
risk for their job such as veterinary and laboratory personnel, their residence or who are 
travelling in endemic regions. It is mainly based on vaccination (WHO, 2013). 
 
 The post-exposure prophylaxis should start as soon as possible after exposure to virus 
and consists of washing of the wound with soap or water, application of human anti-rabies 
immunoglobulin and administration of vaccine according to type of exposure (Table 1.2) and 















Table 1.2. Type of contact, exposure and recommended post-exposure prophylaxis (WHO, 
2013)  
Category Type of contact Type of exposure Recommended post-exposure 
prophylaxis  
I  Touching or feeding of 
animals 
  Licks on intact skin 
None None, if reliable case history is 
available  
II  Nibbling of uncover skin  
 Minor scratches or 
abrasions without bleeding  
Minor  Administer vaccine immediately 
 Stop treatment if the animal 
remains healthy throughout 
period of 10 days or is proved to 
be negative for rabies by a 
reliable laboratory using 
appropriate diagnostic 
techniques 
 Wound management  
III  Single or multiple 
transdermal bites  or 
scratches, licks on broken 
skin 
 Contamination of mucous 
membrane with saliva (i.e. 
licks) 
 Suspect contact with bats  
Severe  Wound management 
 Rabies immunoglobulin 
 Anti-rabies vaccine  
 
b. Control of rabies in dog population  
 The main measures advocated for control of rabies in dog population consist in dog 
population management and vaccination against rabies which must be supported by socio-
economic and administrative determinants such as dog ownership, legislation, public 
awareness, surveillance and laboratory-based surveillance, intersectoral collaboration, 
regional and international collaboration and cooperation (WHO, 1987).  
b.1. Dog population management 
 The dog population management program includes the movement restriction, habitat 
control and reduction of dog density through birth control and culling of stray and rabid dogs 
(Knobel et al., 2007). Jointly with the strict application of the legislation, the dog population 
management has been carried out since half of the 19
th
 century in Europe where it has 
contributed significantly to the control of rabies before discovery of veterinary rabies vaccine 




 The animal birth control (ABC) program of dog population includes surgical 
sterilization (castration, ovariohysterectomy), chemical sterilization (delivery of hormonal 
contraceptives) and confinement of dogs (FAO, 2014). The ABC program in combination 
with vaccination has been proposed in 1960 as way of reducing unsupervised dog numbers, 
dog density, population turnover and rabies incidence, leading to reduction of human bite 
injuries and creating a stable, immunized dog population. Although successful results were 
reported in a number of countries (e.g. India) thanks to ABC program, independent evaluation 
of impact and cost-effectiveness of this strategy is needed ( WHO, 2005; Reece and Chawla, 
2006; Knobel et al., 2007). 
 Culling of dogs is used alone or with vaccination (Kaplan et al., 1954; Larghi et al. 
1988) based on assumption that rabies transmission is dependent on dog density and is likely 
to be maintained endemically in areas where dog density exceeds the threshold for 
persistence, considered to be about 5 dogs/km
2 
(Brooks, 1990; Cleaveland and Dye, 1995; 
Kitala et al., 2002; Lembo et al., 2008). Culling or removal and destruction of dogs is 
considered as contrary to animal welfare and seems to be ineffective in controlling rabies 
(Morters ate al., 2015). Indeed, culling is negatively perceived in society and results in lack of 
community support in fight against rabies. In addition, due to fear of culling, owners may 
relocate dogs to an area where rabies is not currently prevalent or may seek a replacement dog 
from a rabies-prevalent area and reintroduce the disease (Lechénne et al., 2015).  
b.2. Mass vaccination 
 The first effective veterinary vaccine against rabies was an attenuated live virus. It was 
developed in 1920 by Umeno and Doi (1921) in Japan. Then, various rabies vaccines were 
developed and used for the control or elimination of rabies in domestic and wild animals such 
as parenteral (injectable) modified live vaccine, parenteral inactivated vaccine, oral modified 
live vaccine and new generation of biotechnology-derived vaccines (WHO, 2013; Yang et al., 
2013). Since the event of veterinary vaccine, the dog rabies was controlled or eliminated in 
several countries of Europe, North America, Latina America and some Asian countries 
through combination of mass vaccination and classical control measures. Japan was the first 
country to apply mass vaccination of dogs in 1921, whereas Hungary was the first country to 
have experienced the elimination of dog rabies in 1944 through massive vaccination 




 In addition, the routine vaccination of pet animals against rabies is still mandatory 
particularly in rabies endemic countries. Vaccination guidelines are recommended by vaccine 
manufactures and scientists such as the Vaccine Guideline Group (VGP) (Day et al., 2006). 
But each country may adjust the guideline to its epidemiologic situation.  
 
 Field and modelling studies have demonstrated that a vaccination coverage of at least 
40%, called critical threshold, was required to prevent rabies transmission and large outbreaks 
(Coleman and Dye, 1996), whereas a coverage of at least 60%, called control threshold, was 
sufficient for the control or elimination of rabies either through mass vaccination campaigns 
using parenteral (sub-cutaneous injection) vaccination strategy (Steele and Tierkel, 1949; 
Cleaveland et al., 2003; Schneider et al., 2007) or combination of parenteral  and oral 
vaccination strategies (Ben Youssef et al., 1998; Bishop, 2001). The oral vaccination may 
thus allow for improvement in dog vaccination coverage or for the targeting of high-risk, 
inaccessible segments of the population as vaccines are included within attractive bait for oral 
consumption. However, oral vaccines are more expensive. In addition, due to the high affinity 
between dogs and humans, the oral vaccines need to be efficacious as well as safe. Baits 
should be preferentially attractive to dogs and not to non-target species. To date , no universal 
bait has been identified, although many different types have been evaluated successfully 
(Knobel et al., 2007; Cliquet et al., 2018). 
 
b.3. Socio-economic and administrative determinants of dog rabies control 
 The socio-economic and administrative determinants include: (i) the community 
engagement and public awareness which are essential for good dog-keeping-practices , high 
accessibility of dogs to vaccination and thereby increasing the vaccination coverage; (ii) 
surveillance and intersectoral collaboration which are important tools in rabies control, for 
assessment of impact of rabies control program and particularly for the effective and 
economic application of control measures in animals and post-exposure treatment in man, and 
(iii) regional and international technical collaboration that are essential in resource 
mobilization and coordination of control activities (canine rabies elimination in border areas 
and measures governing the import of dogs, cats and other animals able to spread rabies, etc.) 















Chapter 2.  Factors of maintenance of rabies transmission 
in dogs in Kinshasa, Democratic Republic of the Congo 
 
 
The overview provided evidence that rabies is still maintained in dog population in Kinshasa, 
although the incidence is underestimated. This research aimed at unravelling risk factors of 
rabies maintenance in dogs in urban settings and identifying risk zones. It refers to the first 
specific objective of this thesis. The study highlighted two major risk factors of rabies 
transmission in dogs, namely the poor dog-keeping practices and low vaccination coverage. It 
appears that those risk factors are influenced by socioeconomic status of households, thereby 
leading to different risk zones within urban settings. These are low, moderate and high risk 
zones of dog rabies transmission. Finally, the study proposed a tool for establishing a low 
scale risk map that can be used for local risk assessment and targeting high-priority risk 
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 Rabies kills every year 61 000 humans in the world, mainly in Asia and Africa. In 
Democratic Republic of the Congo (DRC), dog rabies is endemic. Despite mandatory 
vaccination of dogs since 1938, disease control remains ineffective. Accordingly, this 
research aimed at unraveling risk factors of rabies maintenance in dogs in urban settings and 
identifying risk zones by combining the dog density, dog roaming behaviour and vaccination 
coverage. The method used to estimate the three factors was a household survey conducted in 
22 study sites of Mont-Ngafula, Ngaliema and Lemba communes in Kinshasa. In addition to 
household survey, (i) a subgroup of owned dogs (n=16) was tracked during 24 hours using 
GPS collars in order to characterize the dog  roaming behaviour, (ii) the feral dog proportion 
was estimated by the street count method , and (iii) the serological evaluation of the 
immunization status of a subgroup of 132 reported vaccinated dogs.  The survey included 
6122 households. In total, 504 dog-owning households with 922 dogs were recorded, 
corresponding to 9% of all households. The mean age of dogs was 2.5 years and 60% of dogs 
belonged to local breeds. Dog density was estimated to 49 dogs/km
2
. Between 2 to 100% 
(mean 60%) of owned dogs were intermittently or continuously free roaming in study sites. 
The mean distance covered by tracked dogs within 24 hours was 0.718 km (0.046-2.341 km) 
and each dog had a chance to come in contact with 30 free-roaming dogs. The proportion of 
feral dogs was less than 2%. The vaccination coverage was 53% (24-81% among study sites). 
The coverage significantly increased with age and was higher in pure and cross breed dogs. 
Associated costs and low age were reported as main reasons for not vaccinating. 73% of the 
132 tested dogs displayed protective anti-rabies antibody titers (≥0.5 IU/ml) irrespective of 
time span since vaccination. By combining the dog density, the percentage of free-roaming 
dogs and the vaccination coverage, the risk map indicated a high risk of rabies transmission in 
41% (9/22) of the study sites. Our study shows that the risk of rabies transmission varies 
locally in urban settings in Kinshasa. Dog-keeping practices and vaccination coverage 
correlate with the socioeconomic status of households and thereby influence the risk level of 
dog rabies transmission. The establishment of a low scale risk map provides a tool for local 








 Rabies is a zoonotic disease responsible for an estimated 61 000 human deaths per 
year in the world, predominantly in Asia and Africa (WHO, 2013). A wide range of mammals 
are susceptible and can transmit rabies. The order of carnivora including domestic dogs 
(Canis lupus), raccoons (Procyon lotor), skunks (Spilogale putorius), foxes (Vulpes vulpes), 
jackals (Canis aureus) and the order of Chiroptera (bats) are considered as reservoirs 
(Sedganti and al., 1990). The dog is responsible for 98% of rabies cases in Africa and Asia 
(Knobel et al., 2005).  
 The first rabies outbreak in Africa was reported in Algeria in 1858 (Steel, 1975). In the 
Democratic Republic of Congo (DRC), the first dog rabies outbreak was reported in 1923 
(Repetto, 1932). Then, from 1938 to 2017, the published and unpublished laboratory data 
revealed that close to 1400 dog rabies cases were confirmed across the country by the three 
national veterinary laboratories of Kisangani, Lubumbashi and Kinshasa (Courtois et al., 
1964; Makumbu, 1977; Bula and Mafwala, 1988; Twabela et al., 2016). In Kinshasa, the 
capital of the DRC, 152 dog-related human rabies cases were reported from 2009 to 2017. 
Most of these victims were children under 15 years old (Muyila et al., 2014; OVCR, 
unpublished data). It is likely that these official rabies data are under-reported. Indeed, active 
surveillance studies illustrated that official reports underestimate the abundance of rabies 
cases in low-income countries such as in Tanzania, Ethiopia and Bhutan (Cleaveland et al. 
2002; Hampson et al., 2008; Deresa et al., 2010; Tenzin et al., 2011; Jemberu et al., 2013). In 
the DRC, field evaluations have evidenced the poor performances of veterinary services. 
These are explained by inefficient surveillance system and limited diagnostic capacity of 
national veterinary laboratories (Niang and Denormandie, 2008; Diop et al., 2012; Ministère 
de la Pêche et de l’Elevage, 2017). 
 Nearly one century after the first reported rabies outbreak (Repetto, 1932), dog rabies 
is still a public health threat in the DRC. Given that the World Health Organization (WHO), 
the World Organization for Animal Health (OIE) and the Food and Agriculture Organization 
(FAO) have set a global target of zero human deaths from dog-transmitted rabies by 2030 
(Global Alliance for Rabies Control,  2015; Wallace et al., 2017; Fahrion et al., 2017), the 
challenge for DRC remains considerable. Despite mandatory rabies vaccination of dogs since 
1938 in DRC (Royal Decree of 01 April 1938) disease control remains ineffective. It is 




and identify regions presenting the highest risk of rabies transmission. Risk factors such as 
dog density, poor dog management leading to free roaming, low vaccination coverage and 
wide biodiversity increasing the number of the rabies virus reservoirs have been identified in 
other countries such as in Zimbabwe, Tanzania (Foggin, 1988; Brooks, 1990; Cleaveland and  
Dye, 1995; Aréchiga et al.,2014), but no data are so far available for DRC. 
 Accordingly, the aims of this study were (i) to investigate the risk factors of rabies 
transmission between dogs in Kinshasa and (ii) to establish a risk map of rabies transmission 
by considering these risk factors. Risk factor assessment included the characterization of the 
dog population and its management as well as the evaluation of dogs’ vaccination coverage 
against rabies in Kinshasa. 
2.3. Materials and methods 
2.3.1. Study area  
 The study area was the capital of DRC, Kinshasa. This megalopolis is divided in 24 
communes, further subdivided in quartiers including plots with one or more households 
(Decree N
o
08/016, 07 October 2008). The study was conducted from January 2017 to March 
2018 in three communes where most dog rabies cases had been reported by the “Office de 
Vaccination et Contrôle de la Rage (OVCR)” in Kinshasa between 2003 and 2017 
(unpublished data), ie Mont-Ngafula, Ngaliema and Lemba. In these communes, 22 quartiers 
were selected as primary sample units (study sites). 
2.3.2. Characterization and management of the dog population  
a. Dog density and population structure 
 A household questionnaire survey was conducted in the 22 study sites by selecting at 
least 20 dog-owning households per site. In each study site, the investigators walked in the 
streets, visited plots and contacted each household until 20 households with at least one dog 
were reached. All households with no dog were also recorded. This purposive sampling was 
done instead of random or systematic sampling because household lists and numbers for each 
study sites were not available. We assumed that households were sufficiently homogenous for 
important selection biases not occurring.  
 A questionnaire was used to collect data including: (i) the number of households on 




dogs, (iv) the number of people living in dog-owning households, (v) the number of people 
living in households with no dogs, (vi) the number of dogs owned per household and (vii) the 
individual description of owned dogs (gender, age and breed). The identified dogs were 
classified according to sex (male, female), age (puppies: less than 3 months, juveniles: from 3 
to 12 months and adults:  more than 12 months old) and breed (local breeds, crossed breeds, 
pure breeds). Data were expressed as relative frequencies. 
 The dog density was estimated from the ratio between the projected human density 
and the estimated Human to Dog Ratio (HDR). The projected human density data was 
obtained from the civil administration. The HDR is one of the best indicators of dog 
population abundance (WHO, 1987; Oboegbulem and Nwakonobi, 1989). It was calculated 
from the ratio between the total number of people recorded in visited households with or 
without dog and the total number of dogs recorded in visited dog owning-households. 
Ownerless dogs (see below) were excluded from the calculation of dog density. 
b. Dog management  
 In order to estimate the proportion of restrained and free roaming owned dogs, the 
household questionnaire also addressed (i) the level of dog confinement (fully tied or caged, 
intermittently tied or caged, free roaming), (ii) the type of plot (plot with or without 
fence/wall or any physical barrier that restrained dog’s movement), and (iii) the dog feeding 
(provided by the owner or ensured by the dog itself during roaming). In addition, the reasons 
for dog abandonment were addressed in open questions. 
 An owned dog was considered as restrained if fencing, tying or caging completely 
prevented its roaming behaviour. All intermittently or non-restrained dogs were considered as 
potentially free-roaming. Results regarding restrained and roaming dogs, as well as reasons 
for dog abandonment were also expressed as relative frequencies. 
 In order to evaluate dogs’ roaming behaviour, 16 free-roaming dogs (8 males and 8 
females) owned by members of the academic staff of the University of Kinshasa (UNIKIN) 
and inhabiting the University campus were tracked during 24 hours using GPS collars. The 
majority of these dogs (15/16) were adults (≥ 12 months). The GPS I-GOTU GT-600 (I-gotU 
company) was programmed to take a GPS location each minute. The maximum distance 
covered by each dog was calculated based on GPS coordinates of the household and the most 




addition, the direct or indirect contact rate of tracked dogs with other free-roaming dogs was 
iteratively estimated in four steps by using the Quantum GIS software (http://www. qgis.org): 
(i) generation of a buffer zone which refers to the potential area covered by a tracked dog. The 
radius of the buffer zone corresponded to the maximum distance covered by each tracked dog,  
(ii) calculation of the area of the administrative (quartier) unit that was covered by the buffer 
zone and that we call “intersection area”, (iii) estimation of the number of potentially free-
roaming dogs per intersection area by considering the calculated dog density and the 
percentage of potentially free-roaming dogs in each respective quartier, and (iv) estimation of 
the contact rate with free-roaming dogs within the buffer zone by summarizing the number of 
dogs in intersection areas. 
 The percentage of feral dogs was assessed in two study sites (Mitendi and Mongala) of 
the communes Monga-Ngafula and Ngaliema by the street count method, which is a 
modification of the sight-resight method (WHO, 1987). A total of 185 (Mitendi) and 110 
(Mongala) owned dogs were identified with a yellow nylon rope used as collar. The following 
day, dog counters walked once in the morning (8 am) and once in the evening (6 pm) through 
the study sites and recorded identified and non-identified free-roaming dogs 
2.3.3. Rabies vaccination 
a. Vaccination coverage  
 The household survey also assessed the vaccination status of owned dogs by 
considering owner’s report (history of vaccination and time point of last vaccination) or the 
vaccination certificate (if available). Reasons for not vaccinating dogs were addressed by 
semi-structured questions. The vaccination coverage was estimated for each study site from 
the ratio between the numbers of reported vaccinated dogs (independently of time since 
vaccination) and the number of identified dogs, including puppies of less than three months.  
The vaccination status of the dogs (binary variable: vaccinated or not) was analysed 
using a cluster robust multivariable logistic regression in STATA software 11.0 (Stata Corp., 
college Station, Texas). Categorical explanatory variables were the sex of the animals (male, 
female), their age categories (puppies, juveniles, adults), their breed (local, crossed, pure 
breeds) and management (free, non-roaming). The robust model, which is more conservative, 
accounts for a possible design effects (DEFT) caused by the 22 study sites considered as 




by calculating and evaluating DEFT for each explanatory variable (Kreuter and Valliant, 
2007). 
 The owner’s reasons for not vaccinating dogs were aggregated and results were 
expressed as relative frequencies. 
b. Serological evaluation of the immunization status of vaccinated dogs  
 Further to oral consent of the owners, 132 supposed vaccinated dogs aged between six 
months and fourteen years of Mont-Ngafula, Ngaliema and Lemba communes underwent 
venous blood collection. Serum was harvested after centrifugation and stored at -20°C. Anti-
rabies antibody detection was performed by Sciensano National Reference Laboratory of 
Rabies in Belgium by use of Rapid Fluorescent Focus Inhibition Test (RFFIT), one of the 
WHO and OIE reference methods (Meslin et al., 1973; OIE, 2014).  
 Antibody titers were expressed in International Units per milliliter (IU/ml) and 0.5 
IU/ml of anti-rabies antibody was considered as the minimum protective titer (WHO 
recommendations, 1992). Results were analyzed as regards of protective antirabies antibody 
titer (< and ≥0.5 IU/ml) and the time span since last vaccination (≤1 year, 1-2 years, 2-3 years, 
>3 years). Using the STATA software, a logistic regression model was used to explore if the 
percentage of vaccinated dogs with protective titer differed by the time span since last 
vaccination.  
2.3.4. Risk map establishment 
The risk of rabies transmission among dog populations was assessed by combining 
results of vaccination coverage, roaming behaviour and dog density in order to establish a risk 
of level 1 (low), 2 (medium) or 3 (high) for each study site. A weighting score was given to 
the different levels of the risk factors, namely vaccination coverage, roaming behaviour and 
dog density. Thresholds were used in order to establish categories of vaccination coverage: ≥ 
60%, 40-60% and <40% (Coleman and Dye, 1996; Hampson et al., 2009); percentage of free 










Table 2.1. Risk factor categories used for establishment of rabies transmission risks among 
dog populations  
Risk factors Weight (%) of 
each risk factor 
(w) 
Threshold Score of each 
threshold              
(s) 
Weighted score of 
each threshold 
(w*s) 
Vaccination coverage (%) 60 
≥ 60
a
 1 0.6 
40-60 2 1.2 
 40
b
 3 1.8 
Percentage of free 
roaming dogs 
30 
≤ 25 1 0.3 
> 25-50 2 0.6 
> 50-75 3 0.9 




 5 1 0.1 
       ≥ 5
c
 2 0.2 
Notes: The risk per study site was the  sum of  three weighted scores  by combination of  three risk factors, which 
could be  equal to 1 (low risk), 2 (medium risk) or  3 ( high risk ). 
a
 Empirical rabies control threshold (Cleveland et al., 2003; WHO, 2013).                                                                                                                                                                                                                                                                                                                                     
b
 Under the critical threshold (Coleman and Dye, 1996; Hampson et al., 2009)                                                                                                                                                
c
Dog density threshold for  rabies maintenance in dogs in endemic regions of Africa (Foggin, 1988; Brooks, 1990, 
Cleaveland & Dye, 1995; Kitala et al. 2002, Lembo et al. 2008)                                                                          
2.4. Results 
2.4.1. Characterization and management of the dog population  
a. Dog density and population structure 
The household survey included 6122 households located in 2914 plots. In total, 504 
dog-owning households with 922 dogs were recorded, corresponding to 9% (95% CI: 8- 10%) 
of all households. In most visited dog-owning households, the dog owner accepted to 
participate in the study. The average number of dogs per dog-owning household was 
estimated to 1.8 dogs (95% CI: 1.7-1.9). The Human to Dog Ratio equaled 53 (95% CI: 49-
57) and the dog density was estimated to 49 dogs/km
2 
(95% CI: 40-58), with a range of 22-90 
dogs/km
2
 in study sites.  
Fifty eight percent of recorded dogs (535/922) were males. Furthermore, close to 60% 
of dogs were adults (≥ 12 months of age), whereas puppies (≤ 3 months of age) represented 
15% of the population. The mean age of dogs was 2.5 years (95% CI: 2.2-2.8) and the 






b. Dog management  
Between 5 and 100% (mean 56%) of plots were insufficiently fenced and did not 
prevent dogs’ roaming as illustrated in Figure S2.1. Regarding intermittently or continuously 
free roaming owned dogs, their percentage ranged from 2 to 100% across study sites (mean 
60%, Fig. 3.1a). The study also showed that 0% to 94% (mean 46%) of dogs were either 
partially fed or not fed by their owners across study sites. 
The analysis of GPS data showed that the 16 tracked dogs covered maximum 
distances ranging from 0.046 to 2.34 km (mean 0.72 km). Maximum distances (> 2 km) were 
covered by males and highest roaming activities were recorded in the morning (before 8 am) 
and in the evening (after 6 pm). The estimated contact rate with other dogs equaled 30 (95% 
CI:23- 37) (Fig. 2.1).  
 Among 201 free-roaming dogs recorded by street count in two study sites, three were 
deemed to be ownerless (1/131 and 2/70). The average proportion of feral dogs was less than 
2%. Regarding owners’ attitude toward dog’s abandonment, only 8% (40 among 504 owners) 






Figure 2.1. Maps showing the real movement of tracked dogs (n=16) within a 24 h period (a) 




2.4.2. Rabies vaccination 
a. Vaccination coverage   
 Fifty three percent (479/922) of dogs were reported to be vaccinated against rabies 
(the vaccination certificate was available for 89% of these dogs) and no differences with 
regard to sex and roaming behaviour were found. Vaccination coverage increased with age 
and was higher in pure and cross breed dogs (Table 2.3). Vaccination coverage ranged from 
24% to 81% among study sites and was below the critical threshold of 40% in 8 of the 22 
study sites (Fig. 2.3b). Associated costs and low age were reported as main reasons for not 
vaccinating dogs (Table 2.2). 
Table 2.2. Owner’s stated reasons for not vaccinating dogs against rabies  
Reasons of non vaccination  Number of 
answers  
Percentage  
The lack of money or the high cost of the rabies 
vaccination  
194 46% 
The dog is too young  (≤3 months or  <1 year )  152 36% 
The dog is not aggressive  68 16% 
The lack of knowledge of the disease and the importance 
of vaccination  
62 15% 
The ignorance of the location of veterinary services  61 14% 
The dog is completely restrained (no roaming) 59 14% 
The negligence  32 8% 
The vaccination side effects (loss of agressivity, death), the 
vaccinator’s credibility 
26 6% 
The rabies vaccination is the Government’s responsibility 14 3% 
The bitch was vaccinated  14 3% 
No data 9 2% 
Total of answers 424   
b. Serological evaluation of the immunization status of vaccinated dogs  
 Seventy three percent of a subgroup of 132 reported vaccinated dogs displayed 
protective anti-rabies antibody titers (≥0.5 IU/ml). The percentage of protected dogs tended to 
decrease in function of time span since last vaccination from 81 to 63%, but this was not 
statistically significant (p=0.4, Fig. 2.2). Regarding dogs’ age at the time of the first or last 
vaccination, dogs were vaccinated at about 12 months of age (median), ranging from 3 to 115 
months. Independently of dogs’ age at vaccination, the median time span since last 






Figure 2.2. Distribution of serological status of reported vaccinated dogs in function of time 
since last vaccination: a:  ≤1 year; b: 1-2 years; c: 2-3 years; d: >3 years. The proportion of 
dogs with protective titre (>0.5 IU/ml) does not differ between groups (p=0.4, logistic 
regression model). 
2.4.3. Establishment of a risk map  
 The combination of vaccination coverage, roaming behaviour and dog density 
revealed that the risk level of rabies transmission among dog populations was 1 (low), 2 
(medium) and 3 (high), respectively, in 27% (6/22), 32% (7/22) and 41% (9/22) of the study 
sites (Fig. 2.3c).  
 
Figure 2.3. Selected study sites (quartiers) in Mont-Ngafula, Ngaliema and Lemba 
communes. (a) Estimated percentage of owned dogs which are potentially free to roam. (b) 
Estimated vaccination coverage. (c) Qualitative assessment of the risk of dog rabies 
transmission in study sites based on dog density, dog vaccination coverage and percentage of 




Table 2.3. Characteristics of reported rabies-vaccinated dogs among 922 owned dogs, using a cluster robust logistic regression and multivariable model 




OR(95%CI) P value Prediction of vaccination 
coverage  (95% CI) 
Sex        
Male
a
 525 57 305   58 (54-62) 
Female 397 43 305 1.5 (0.9-2.3) 0.113 52 (47-57) 
Age categories        
Adults (>12 mo)
a
  504 56 380   74 (70-78) 
Juveniles (3-12 mo) 280 30 122 13 (2.3-
76.7) 
0.001 44 (38-50) 
Puppies (≤ 3  mo) 129 14 8 61 (9-413) 0.001 6 (3-11) 
Dog management       
Non-roaming dogs
a
 390 42 273   70 (65-74) 
Free- roaming dogs 532 58 237 1.6 (0.8-2.9) 0.111 45 (40-49) 
Dog breeds       
Pure breeds
a
 106 12 101   95 (89-98) 
Crossed breeds 271 29 174 3 (2.2-5.2) 0.001 64 (58-70) 
Local breeds 545 59 235 23 (8.6-
62.7) 
0.001 43 (39- 47) 
  Abbreviation: mo months 
a









The present study aimed at unravelling risk factors of rabies transmission maintenance 
in dogs and identifying risk zones risk zones by combining the dog density, dog roaming 
behaviour and dog vaccination coverage.  
The method used to estimate the three factors was the household questionnaire survey 
for which the accuracy of estimates (vaccination coverage, dog density) was not proven to be 
significantly different of those from census method, which is considered as the gold standard 
method (Cleaveland et al., 2003; Minyoo et al., 2015). In particular for dog density 
calculation, our method aimed at increasing the accuracy by considering the number of people 
living in households with no dogs in the calculating of HDR given the poor accuracy of 
available human population data and the lack of dog population data. Indeed, the last 
population census in the DRC was conducted in 1984 and the rural-urban drift is increasing 
(Flouriot, 2013), thereby justifying an update. Although the registration of dogs at the 
veterinary services is mandatory since 1918 (Royal Decree of 22 January 1918) in the DRC, 
the law is not respected by owners.  
Possible biases include response, classification and selection biases. The response bias 
was low since people were found in most households and very few refused to answer the 
questionnaire. Mis-classification could occur as people might fear to declare they owned dogs 
that were not vaccinated. Finally, a selection bias could have occurred because of the 
purposive sampling strategy.  
Presently, the inclusion of the dog density among risk factors of rabies transmission in 
dog populations is debatable. On one hand, several field and modelling studies demonstrated a 
density-dependency of rabies transmission in Africa, where the disease persists in dog 
populations with a density > 5 dogs/ km
2
 and only sporadically appears under this threshold 
(Foggin, 1988; Brooks, 1990, Cleaveland and Dye; 1995; Kitala et al. 2002). On the other 
hand, the study of Morters et al. (2013) found no conclusive evidence that support the 
relationship between dog density and rabies transmission. In our study, dog density equaled 
49 dogs/km
2
, which is almost ten times more than the above threshold density (5 dogs/km
2
). 
Densities varied depending on quartiers (min 22 – max 90 dogs/km
2
). 
 The second risk factor was the poor dog management because more than 50% of 




roaming were the absence of a physical barrier that permanently prevented dogs from roaming 
and the owners who voluntarily allow dogs to roam in search for food in public dumps and 
open markets.  
 The total roaming restriction of all dogs should be the first measure of rabies control at 
the community level as applied in parts of Europe before implementation of vaccination 
programs (Wallace et al., 2017). In Kinshasa, the total restriction of dogs is not feasible due to 
above mentioned reasons of abundance of free-roaming dogs. However, it can be considered 
that most free-roaming dogs might be easily captured and punctually caged or tied for 
vaccination as they have owners. Indeed, apparently feral dogs accounted for less than 2% of 
the free-roaming dog population in the two study sites. The term “apparently feral dog” was 
used instead of “feral dog” because the street-count method used to estimate the percentage of 
ownerless dogs could not exclude the presence of owned and feral dogs from neighbouring 
areas. The estimated percentage of ownerless dogs was low (≤ 2%) and in line with estimates 
of 0–11% ownerless dogs in Zimbabwe, Tanzania and Chad (Butler and Binghame, 2000; 
Cleaveland, 2014). Considering the mean quartier size (6,1 km
2
), the mean roaming distance 
of dogs (0.72 km) and the roamed surface (1.6 km
2
), it can be hypothesized that roaming 
dogs, whether they are owned or not, mainly roam within one or two quartiers. Such 
information is important for vaccination campaigns because it suggests that high vaccination 
coverage could be achieved very locally. Given the reduced (n=16) number of dogs whose 
roaming behaviour was assessed by GPS tracking, further investigations implying a larger 
number of dogs that are housed in different study sites would be useful. 
Vaccination against rabies remains the key component of rabies control as shown by 
the strong correlation between high vaccination coverage and low rabies incidence 
demonstrated in several studies. Indeed, the empirical vaccination coverage of ≥ 60% has led 
to a significant reduction of rabies outbreaks (Korns and Zeissig, 1948; Cleaveland et al., 
2003; Hampson et al., 2009; Morters et al. 2013; Global Alliance for Rabies Control, 2015). 
In contrast, rabies outbreaks occur when the immunization coverage falls under the critical 
threshold of 40% (Coleman and Dye, 1996; Hampson et al., 2009). Several methods can be 
used to estimate the vaccination coverage (Minyoo et al., 2015). In the present study, the 
household questionnaire survey recorded vaccinated dogs regardless of the time span since 
last vaccination. Among 132 blood-sampled dogs, 73% showed a protective antirabies 
antibody titre (≥0.5 IU/ml) and the impact of time span since last vaccination was not 




observed as the time since vaccination increased and the recommendation for annual 
vaccination in dogs (Arrêté N
o
SC/151/BGV/MIN/AGRI & DR/SMI/2016) is still valid. These 
results further suggest that a proportion of vaccinated dog populations with a poor turnover 
would be protected against rabies for more than one year. Furthermore, it can be speculated 
that reported vaccinated dogs without protective antirabies antibody titres (27 % of dogs with 
<0.5 IU/ml) had nevertheless been immunized against rabies and that they would display a 
rapid memory immune response upon exposure. On the other hand, a lack of quality (potency) 
of the vaccine due to an inadequate cold chain during vaccine storage or non-responding dogs 
could also account for absence of protection (Day et al., 2016). 
 By considering the vaccination history of all owned dogs through the household 
questionnaire, the overall vaccination coverage equaled 53% and was above the critical 
coverage level of 40% (Coleman and Dye, 1996; Hampson et al., 2009). However, the 
coverage significantly differed between study sites and ranged from 24 to 81%. In addition, 
coverage in 36% (8/22) of study sites was below the critical immunization of 40%, which is 
propitious for rabies outbreaks (Hampson et al., 2009). It is important to emphasize that the 
low coverage (40%) was estimated particularly in areas with low proportions of restricted 
dogs (Fig 2b). The variability of coverage between study sites is likely to be linked to the 
differences of the socio-economic situation of their inhabitants. Despite mandatory 
vaccination of dogs against rabies in DRC (Royal Decree of 01 April 1938), vaccination is not 
fully applied in the field and must be afforded by the dog owners. Indeed, the current cost (20 
USD) for rabies vaccination appears as the first reason of non-vaccination for 46% of the 
interviewed dog owners (Table 2.2). Given that in DRC 70% of people live under the poverty 
threshold (Moummi, 2010), it might be expected that low-income households own non-
vaccinated dogs. Another consequence of poverty is a poor dog management: local and 
crossed breeds are less expensive (Kazadi et al., 2017) and are allowed to roam freely, 
whereas pure breeds predominantly live in fenced plots.  
 The dogs’ age was another factor limiting vaccination. Most of the dogs under one 
year of age, and mainly puppies (≤ 3 months of age), were often unvaccinated. The WHO 
recommends the inclusion of puppies of less than three months of age in the rabies 
vaccination programs (WHO, 2013). Indeed, puppies are susceptible sub-populations and 
published laboratory data show that 4 to 17% of confirmed rabies cases are puppies under 
three months (Perry, 1993; Widdowson et al., 2002; Reta et al., 2014; Morters et al., 2015). 




young for vaccination. As a consequence, 94% (121 of 129) puppies, presenting 14% of the 
dog population were not vaccinated (Table 2.3). 
Finally, the combination of the three main risk factors in form of a risk map reflected 
the likelihood of rabies transmission. This risk was found to be high and medium respectively 
in 41% (9/22) and 32% (7/22) of study sites (Fig 2.3c). In addition, it is likely that quartiers 
that are close to high risk sites should be cautiously regarded as high risk sites. This key result 
correlates closely with the rabies epidemiological context (unpublished laboratory dog rabies 
data). The high risk level of rabies transmission was associated to poor dog-keeping practices 
and to low vaccination coverage. Both factors were tightly linked to the socioeconomic status 
of dog-owning households. Indeed, some dogs were not exclusively feed by the owners and 
were therefore allowed to roam freely. Furthermore, the cost of vaccination (ie 20 USD in 
DRC) is not affordable to most of owners in impoverished suburbs (Kazadi et., 2017). An 
association of increased risk for canine rabies and areas of low socioeconomic status has also 
been shown in Mexico and Bolivia based on positive rabies samples from different urban 
settings (Eng et al., 1993; Widdowson et al., 2002). In China, the low vaccination coverage 
and the growth of uncontrolled dog populations as a consequence of socio-economic changes 
were the main causes of rabies re-emergence in poor communities (Yin et al., 2013). Based on 
these evidences, the combination of the three main risk factors in form of a risk map provides 
a tool for the field assessment of rabies risk in urban settings. It should be added that in peri-
urban and rural settings, the role of wild animals in the maintenance of rabies in dog needs 
further investigations.  
2.6. Conclusion 
 Our study shows that the risk of rabies transmission varies locally in urban settings in 
Kinshasa. Dog-keeping practices and vaccination coverage correlate with the socioeconomic 
status of households and thereby influence the risk level of dog rabies transmission. The 
establishment of a low scale risk map at the level of quartiers and by considering vaccination 
coverage, roaming behaviour and dog density provides a tool for local risk assessment and 




















Chapter 3. Evaluation of dog vaccination schemes against 
rabies in Kinshasa, Democratic Republic of the Congo 
 
  
Based on rabies transmission risk zones set up in Chapter 2, this study aimed at proposing a 
risk-based vaccination strategy for rabies control in dog population. It corresponds to the 
second specific objective of this thesis. Four settings were targeted: two settings with low risk 
and low roaming dog population and two others with high risk and high roaming population. 
This study evidenced the link between the dog-keeping practices and dog turnover rate. Dog 
turnover was high in settings with poor dog-keeping practices (high roaming dog population) 
and high risk of rabies transmission, leading to rapid removal of vaccinated dogs, increase of 
susceptible dogs made up mainly of dogs less than 12 months of age , and conversely, to rapid 
decrease of proportion of vaccinated animals in the population. On the other hand, the 
systematic vaccination of puppies at weaning (3 months of age) results in a sufficient 
proportion of immune animals in high risk and high turnover rate settings. Assuming that a 
single vaccination at 3 months protects the animal for 3 years at least, the implementation of 
systematic vaccination of puppies at weaning seems to be efficient and more appropriate 
rabies vaccination strategy for rabies control in resource-poor and endemic countries, 
despite high turnover rates.  
 
 





 Dog-mediated human rabies is still endemic in Democratic Republic of the Congo 
(DRC), despite the fact that the disease can be controlled through mass dog vaccination 
campaigns that are not regularly organized in Kinshasa. No strategy is properly applied 
probably either because the State is unable to allocate resources for rabies control or due to 
inability of dog owner to afford vaccination costs. Given the existence of different risk zones 
countrywide, the efficiency of vaccination strategy may be improved by targeting high-risk 
zones. Therefore, the present study aimed at proposing a risk-based vaccination scheme by 
considering (i) the canine population dynamics with different risk profiles for rabies 
transmission and (i) the efficacy and duration of a serologically-detectable immunity in 
response to vaccination and revaccination tested under field conditions. The capital of DRC, 
Kinshasa, was chosen as study site for this rabies vaccination outcome model. The population 
dynamics was carried out in two low roaming populations (<25% of dogs are roaming) and in 
two high roaming zones (>75% of dogs are free roaming). Results evidenced the link between 
the dog-keeping practices and the turnover rate. It was twice as high in dog roaming settings 
(36%) as that in low-roaming zones (17%). Similar differences were found for birth rates 
(45% versus 32%) and dog removal rates (40% versus 9%). Irrespective of roaming level, dog 
populations were young: 75% of dogs were less than 3 years old. The vaccine was equally 
effective (p=0.24) in puppies (2-3 months: 96%), juvenile (3-12 months: 97%) and adult dogs 
(>12 months: 100%). The assessment of vaccine efficacy in terms of serological response to 
primo-vaccination showed that the vaccine was effective in 93% (11/12) of puppies that had 
no prevaccinal protective titers (≥0.5 IU/ml). The memory or anamnestic response was strong 
and rapid within 5-8 days upon the booster vaccination, in 96% (45/47) of dogs reported 
vaccinated for 1 to 7.5 years. This suggests that the duration of immunity provided by the 
rabies vaccine is lasting more than 3 years. Thus, given the short life expectancy (≤3 years) of 
75% of surveyed dogs, it was hypothesized that vaccine may provide a lifetime protection 
against rabies for the majority of the investigated dog population. Considering the setting-
specific turnover rate and the critical threshold of 40% under which rabies outbreaks occur, an 
initial proportion of 80% of immune dogs drops below 40%, respectively after 27 months in 
low risk and low dog turnover rate (17%) and 18 months in high risk and high turnover rate 
(36%). In contrast, when dogs are systematically vaccinated at 3 months of age, the 
proportion of immune dogs is maintained even in high risk and high turnover rate, thereby 




Annual vaccination campaigns, if implemented with a sufficient coverage, result in severely 
varying proportions of vaccinated animals in a year (high after vaccination and low just 
before). Theoretically, the implementation of systematic vaccination of puppies at weaning 
seems to be efficient and more appropriate rabies vaccination strategy for rabies control in 
resource-poor and endemic countries, despite high turnover rates.  
3.2. Introduction 
 Rabies is an acute meningoencephalitis due to a lyssavirus. The disease is fatal in 
humans in absence of early treatment. Every year, rabies is responsible for more than 60,000 
deaths across the world mainly in Asia and Africa (WHO, 2013). In Africa, close to 98% of 
human rabies cases are due to dog bites (Knobel and al., 2005). Dogs are considered as the 
main vector of the disease. In the Democratic Republic of Congo (DRC), dog rabies is 
endemic (Courtois et al., 1964; Makumbu, 1977; Bula and Mafwala, 1988; Muyila et al., 
2014, Twabela et al., 2016). The disease burden is underestimated due to inefficient 
surveillance systems and limited diagnostic capacities of national veterinary laboratories 
(Niang and Denormandie, 2008; Diop et al., 2012; Ministère de la Pêche et de l’Elevage, 
2017).  
 The elimination of dog-mediated human rabies is feasible through mass vaccination of 
dogs as successfully demonstrated in Europe, America and the Caribbean Islands (WHO, 
2013; Taylor and Nel, 2015). Empirical and modelling studies show that an annual 
vaccination coverage of at least 60% of the dogs leads to rabies control (Cleveland et al., 
2003; Hampson et al., 2009; WHO, 2013). Annual mass vaccination of dogs aims at 
maintaining the proportion of immune dogs high. Indeed, the vaccination coverage of at least 
60% is considered as appropriate for disease control, whereas a herd immunity below the 
critical threshold of 40% strongly raises the probability of rabies outbreaks (Coleman and 
Dye, 1996; Hampson et al.,2009). In Africa, the proportion of immune dogs declines quickly 
because of high dog turnover rates (30%) and exclusion of puppies (≤ 3 months) from 
vaccination programs (Coleman and Dye, 1996, Hampson et al., 2009; Morters et al., 2015). 
Another reason for annual mass vaccination is that some countries such as DRC requireannual 
vaccination boosters (Arrêté N
o
SC/151/BGV/MIN/AGRI & DR/SMI/2016; Day et al., 2016).  
 A review on dog rabies vaccination coverage in Africa showed that the coverage is 
close to 70% following a free of charge mass vaccination, but can easily fall to 18% if dog 




vaccination campaigns are not implemented in most of Sub-Saharan countries (Hotez and 
Kamath, 2009). Owners’ compliance towards mandatory vaccination strongly depends on 
their socio-economic situation and the subsequent ability to afford vaccination costs. It further 
appears that the dog management is also influenced by socio-economic factors, thereby 
leading to different risk zones within countries and within towns (Kazadi et al., 2020). 
Accordingly, the efficiency and cost-effectiveness of rabies control could be improved by 
considering the canine population dynamic of different risk zones. In this context, it would 
further be interesting to question the benefit provided by annual revaccination. 
The aim of this study was to propose a risk-based vaccination scheme or model by 
considering (i) canine populations with different risk profiles for rabies transmission and (ii) 
the efficacy and duration of a serologically-detectable immunity in response to vaccination 
and revaccination tested under field conditions. The capital of DRC, Kinshasa, was chosen as 
study site for this rabies vaccination outcome model. 
3.3. Material and methods 
3.3.1. Study design 
 Population structure and dynamics in dogs was assessed in two low and two high risk 
rabies transmission areas (Kazadi et al, 2020). Low transmission risk was linked to dog 
populations with low roaming activity (<25% of dogs are roaming) and high rabies 
vaccination coverage (≥60%), whereas high transmission risk was associated with high 
roaming activity (>75% of dogs are free roaming) and low vaccination coverage (40%). 
 The efficacy of a serologically-detectable immunity was assessed in response to 
primo-vaccination in dogs belonging to different age groups (puppies, juvenile dogs, adult 
dogs) whereas the duration of immunity was evaluated serologically by revaccination in 
previously vaccinated dogs and by considering time span since vaccination and revaccination.  
 These data as well as initial immunity levels were used to implement a rabies 
vaccination outcome model allowing prediction of the impact of vaccination strategies on 





3.3.2. Study area  
 The study area was Kinshasa, the capital of the DRC, which is administratively 
subdivided in 24 communes further subdivided in quartiers (Decree N
o
08/016, 07 October 
2008). Selected communes and quartiers are detailed in Figure 3.1 and Table 3.1. Areas of 
low transmission risk were Righini and Ngomba Kinkussa, whereas Livulu and Mongala were 
considered as quartier with a high risk of transmission (Kazadi et al., 2020). Serological 
assessment of rabies immunity was assessed in different communes based on dog owner 
compliance.  
 
Figure 3.1. Map showing the communes of Kinshasa. Areas in grey indicate the communes where 










Table 3.1. Communes and quartiers of Kinshasa concerned by data and sample collection   
N
o
 Study Study area Data or sample 
collection period  
1 Dynamic of dog population  Four quartiers (Livulu, Righini, Ngomba-
Kinkussa and Mongala) located  in 
Lemba, Ngaliema and Bumbu communes  
December 2017 to 
December 2018 
2 Serological evaluation of 
efficacy of  rabies vaccine 
Communes: Lemba, Mont-Ngafula, 
Ngaliema, Bumbu and Ngaba 
Day 0 and Day 30 
(2018) 
3 Serological estimation of 
duration of immunity 
provided by rabies vaccine  
Communes: Lemba, Mont-Ngafula, 
Ngaliema, Bumbu and Ngaba 
Day 0 and Day 8 
(2018) 
3.3.3. Data collection and analysis 
a. Study of the dog population dynamics 
 A longitudinal demographic survey was conducted in the four selected quartiers from 
December 2017 to December 2018 (Table 3.1). Dogs were identified in dog-owning 
households that accepted to participate in the study. The following data were collected 
through three visits (December 2017, June 2018 and December 2018): (i) number of dogs 
owned, (ii) their sex and age (iii), reproductive history of females including litter size, (iv) 
fate of pups (i.e. kept, sold, given away or died), (v) number of newly arrived dogs, (vi) 
number of previously recorded dogs which were no longer present (died, sold, given away or 
stolen) at  the next visit.    
 Collected data were used to estimate the following parameters: (i) the age of the third 
quartile (75%) of dogs, (ii) mean litter size and the pup mortality, (iii) reproduction rate (ratio 
between number females that had given birth and number of females recorded), (iv) birth rate 
(ratio between number of puppies born and number of recorded dogs), (v) growth rate, and 
(vi) the turnover rate of the population. The dog population growth rate was estimated as the 
natural log of the final population (P1) and the initial dog population (P0) or ln (P1/P0) 
(Caughly, 2004; Czupryna et al., 2016). The turnover rate was calculated as the ratio between 
new dogs and the final population (P1). New dogs included dogs that were born between the 
first and the third visit and those that were newly acquired.  
b. Serological evaluation of the efficacy of rabies vaccine   
 The efficacy of rabies vaccine was tested in three age groups composed of 24 puppies 
(≤ 3 months of age), 37 juvenile dogs (3-12 months) and 22 adult dogs (>12 months). All 




Rabisin (Merial, 1IU/ml). Vaccines were purchased from a veterinary drugstore in Kinshasa. 
Venous blood was sampled the day of vaccination (D0) and one month later (D30). Serum 
was harvested after centrifugation and stored at -20°C. Anti-rabies antibody detection was 
performed by Sciensano National Reference Laboratory of Rabies in Belgium by use of Rapid 
Fluorescent Focus Inhibition Test (RFFIT), one of the WHO and OIE reference methods 
(Meslin et al., 1973; OIE, 2014).  
Anti-rabies antibody titers were expressed in International Unit per milliliter (IU/ml) 
and 0.5 IU/ml of anti-rabies antibody was considered as the minimum protective titer 
according to the WHO recommendations (1992). The rabies vaccination was considered 
effective if the D30 titer was ≥0.5 UI/ml for dogs with D0 titer below the 0.5 IU/ml cut-off or 
if the D30 titer increased in dogs with starting titer ≥0.5 UI/ml. Anti-rabies antibodies was 
considered as undetectable if the titer was below 0.18 IU/ml. 
 Using the STATA software 11.0 (Stata Corp., college Station, Texas) a logistic 
regression model was used to explore if the percentage of protected dogs (titer ≥0.5 IU/ml) 
after vaccination differed between the three age categories (puppies, juveniles and adults). 
c. Serological estimation of the duration of immunity in vaccinated dogs   
 The duration of immunity was estimated by determining serum antibody titer before 
(D0) and 5-8 days after (D8) administration of a booster vaccine in dogs whose last 
vaccination was performed since >1-2 years (n=31), >2-3 years (n=12) or >3-7.5 years (n=4). 
The RFFIT was used to quantify anti-rabies antibodies before and after the booster 
vaccination.  
 The proportion of dogs with protective titers (≥0.5 IU/ml) or without protective titers 
(<0.5 IU/ml) was calculated at D0 and D8. The anamnestic response was considered adequate 
in case of a titer rise at D8 of at least 0.5IU/ml. The duration of the immunity provided by 
rabies vaccine was estimated based on proportion of dogs with protective titer after the 
booster vaccination considering the time span since the last vaccination.  
 Using the STATA software 11.0 (Stata Corp., college Station, Texas) a logistic 
regression model was used to explore if the percentage of protected dogs (titer ≥0.5 IU/ml) 
following the booster vaccination was influenced by time span (years) between last and 




d. Vaccination compartmental model 
 The compartmental model aimed at estimating the rabies vaccination coverage in dog 
populations presenting low and high rabies transmission risk profiles. This model was adapted 
from the mathematical model published by Chidumayo (2018). 
 The present mathematical model was subdivided in three age compartments: (i) 
puppies (P: 0-3 months), (ii) juveniles (J: 3-12 months) and adults (A: >12 months). In 
addition, a vaccination compartment was created for juveniles only. Finally, 3 compartments 
of unprotected animals (J2, J3, A2) included unvaccinated animals and vaccination failure, 
and two rabies protection compartments (protected dogs) for juvenile (J1) and adult (A1) 
classes (Table 3.2). 1 and 2 were aging rates for transfer from compartments P to J and J to 
A respectively. p1 and p2 were respectively the vaccination proportion in puppies at 3 months 
and the proportion of juveniles dogs vaccinated each 6 months (3-12 months). Gamma () was 
the vaccination success rate. Removal rates were denoted mu () 1 to 3 for P, J and A 
compartments respectively (Fig. 3.2). 
Table 3.2. Model core parameters 






(25%)   
Area with high- 
roaming 
activity (≥75%)   
Juvenile female proportion
a
 JFP Dimensionless 0.49 0.44 
Adult female proportion
b
 AFP Dimensionless 0.40 0.38 
Puppy removal rate (0-3 mo) 1 Month
-1
 0.04 0.08 
Juvenile removal rate (3-12 mo) 2 Month
-1
 0.036 0.05 
Adult removal rate (>12 mo) 3 Month
-1
 0.016 0.026 
Puppy maturation rate  1 Month
-1
 0.30 0.30 
Juvenile maturation rate (3-12 mo) 2 Month
-1
 0.063 0.052 
Juvenile reproduction rate (3-12 mo) 1 Month
-1
 0.009 0.018 
Adult reproduction rate (>12 mo) 2 Month
-1
 0.019 0.033 
Litter size LS Dimensionless 5 5 
Proportion of vaccinated weaned 
puppies at 3 months of age  
p1 Month
-1
 0.8 0.8 
Proportion of juvenile dogs (3-12 
months) vaccinated each 6  months 
p2 Year
-1
 0.8 0.8 
Estimated vaccination success
c 
   Dimensionless  0.9 0.9 
Notes: mo months 
a
 Proportion in juvenile dogs 
b
 Proportion in adult dogs 
c 
Serological and challenge studies 






Figure 3.2. (a) Flow diagram of systematic vaccination of puppies at 3 months of age. The population was 
subdivided in three age compartments: (i) puppies (P: 0-3 months), (ii) juveniles (J: 3-12 months) and adults (A: 
>12 months). In addition, a vaccination compartment was created for juveniles only. Finally, 3 compartments of 
unprotected animals (J2, J3, A2) included unvaccinated animals and vaccination failure, and two rabies 
protection compartments (protected dogs) for juvenile (J1) and adult (A1) classes. 1 and 2 are aging rates for 
transfer from compartments P to J and J to A respectively. p1 is the vaccination rate in puppies at 3 months and 
p2 is the proportion of juvenile dogs vaccinated each 6 months. Gamma () is the vaccination success rate. 
Removal rates are denoted mu () 1 to 3 for P, J and A compartments respectively. (b) Flow diagram of annual 
vaccination of juvenile dogs (3-12 months). Juvenile dogs are transferred from unvaccinated subpopulation (J2) 








The following differential equations were used in order to test scenarios of: 
a. Systematic vaccination of puppies at 3 months of age  
dP/dt = ((A1+A2) * AFP*2 * LS) + ((J1+J2+J3) * JFP*1 * LS) – (P * 1) – (P  *1) (1) 
dJ1/dt =  ((p1*) * P * 1) – (J1 * 2) -  (J1 * 2) (2) 
dJ2/dt = ((1 - ) * p1 * P *1) - (J2 *2) - (J2 * 2) (3) 
dJ3/dt = ((1-p1) * P * 1) – (J2 *2) - (J2 * 2) (4) 
dA1/dt = (J1 *2) - (A1*3) (5) 
dA2/dt = (J2 *2) + (J3 *2) - (A2*3) (6) 
b. Annual vaccination of juvenile dogs (3-12 months)  
dP/dt = ((A1+A2) * AFP*2 * LS) + ((J1+J2+J3) * JFP*1 * LS) – (P * 1) – (P  *1) (1) 
dJ1= ifelse(times%%6<1, p2*J2, 0) - (J1* u2) – (J1 * 2) 
dJ2= (P*1) – ifelse (times%%6<1, p2*J2, 0)- (J2 * u2) 
dJ3= ifelse(times%%6<1, (1-p2) *J3, 0) - (J3 *u2)- (J3 *2 ) 
dA1= (J1 * 2) - (A1 * u3) 
dA2= (J3 *2 ) - (A2 *u3) 
Parameters are detailed in Tables 3.2. 
 Dog population values (number of puppies, juveniles and adults) were initialized by 
running the model 1000 times. Dog population stability was verified (plausible population 
growth, given birth and disappearance rates set). Population abundance values obtained after 
the convergence of the model were used to calculate the proportion of puppies, juveniles and 
adults. Initial values were calculated accordingly for the different dog categories (Table 3.3.) 
Table 3.3. Age-related model parameters  
Model parameters  
Symbol Area with low -
roaming activity 
(25%)  












Puppy proportion  (0-3 months) P 0.15 0.09 0.18 0.14 
Juvenile proportion (3-12 months) J1+ J2 +J3 0.15 0.21 0.28 0.35 
Adult proportion  (>12 months) A1+A2 0.70 0.70 0.54 0.51 
Abbreviations: P puppies, J1 vaccinated and non protected juveniles, J2 unvaccinated juvenile , J3 vaccinated 





The following scenarios were tested: (i) Impact of complete vaccination stop in high and low 
risk populations presenting an initial vaccination coverage of 60% and 80%; (ii) impact of 
systematic puppy vaccination in high and low turnover rate populations with an initial 
vaccination coverage of 0%, 24% (coverage recorded in high risk populations in Kinshasa; 
Kazadi et al 2020) or 60%, and (iii) impact of biannual pulse vaccination of juvenile dogs (3-
12 months) in low and high turnover rate populations with an initial coverage of 0%, 24% 
(coverage recorded in high risk populations in Kinshasa; Kazadi et al 2020) or 60%. 
3.4. Results 
3.4.1. Dog population dynamics   
 The characteristics of the dog population are displayed according to low or high 
roaming activity and subsequent rabies transmission risk in Table 3.4. The dog turnover rate 
in areas with high-roaming dog activity was twice (36%) as high as in areas with low-roaming 
dogs’ activity (17%). Similar differences were found for reproduction rates in adult (39% 
versus 23%) and juvenile (22% versus 11%) females. The annual disappearance rate was 9% 
in area with low-roaming activity and 40% in area with high dog roaming activity. 
 The dog population was young: 75% (third quartile) of identified dogs in areas with 
low and high turnover rate were less than 3 years old. The median age of dogs did not differ 
between areas (p=0.24) and was respectively 14 and 24 months in high and low-roaming 
activity areas. Adult dogs aged 5 years represented less than 10% of identified dogs (Fig. 3.3). 
However, the age structure differed between areas: puppies (0-3 months) and juvenile dogs 
(3-12 months) made up 46% of dog population in high risk and high turnover rate settings, 











Table 3.4. Characteristics of the investigated dog population in Kinshasa between 2017 and 2018  
Demographic parameters  Letter 
code 
Formula Area with  











Number of visited dog-owning households      
2017 a  112 190 
20118 b  112 190 
Number of recorded dogs     
2017 c  153 280 
2018  d  178 270 
Number of disappearing dogs between 2017 
and 2018  
e  16 109 
Number of newly enrolled dogs  f  31 99 
Growth rate  g ln(d/c)
a
 0.15 -0.03 
Turnover rate  h f/d 0.17 0.36 
Number of adult females (>1 year) i  42 51 
Number of adult females that had given birth 
between 2017 and 2018 
j  10 20 
Adult reproduction rate  k j/i 0.23 0.39 
Mean litter size of adult female  l  5 5 
Number of juvenile female (<1 year) m  18 27 
Number of juvenile females that had given 
birth between 2017 and 2018 
n  2 6 
Juvenile reproduction rate  o n/m 0.11 0.22 
Mean litter size of juvenile females  p  4 4 
Number of  puppies born  q l*j+p*n 58 124 
Birth rate  r q/d 0.32 0.45 
Disappearance rate  s e/d 0.09 0.40 
a
 Calculation of growth rate according to Caughly (2004) and  Czupryna et al. (2016) 
 
Figure 3.3. Age distribution of identified dogs in areas with low (n=178) and high (n=280) proportion 





Figure 3.4. Age structure of dog population respectively in (a) low risk and low turnover rate 
(n=178) and (b) high risk and high turnover rate (n=280)  
3.4.2. Serological evaluation of the efficacy of rabies vaccine in puppies, juvenile and 
adult dogs 
 At D0, the proportion of recruited dogs with protective anti-rabies antibody titers was 
47% (39/83). This surprisingly high proportion varied from 41 to 55% and did not differ 
between age groups (p=0.89) (Fig, 3.5).  
 At D30, the proportion of protected dogs (titer ≥0.5 IU/ml) equaled 98% (81/83) and 
ranged from 94% to 100% without differing between age groups (p=0.24) (Fig. 3.5). 






Figure 3.5. Proportion of puppies, juvenile and adult dogs presenting protective anti-rabies antibodies 
titers (≥0.5 IU/ml) before (D0) and after (D30) rabies vaccination. No group-related differences 
between vaccine responses were found (p=0.24). 
3.4.3. Serological estimation of the duration of immunity in vaccinated dogs   
 Before booster vaccination at D0, the proportion of dogs with protective titers equaled 
74% (35/47) and did not differ in function of time span since last vaccination (p=0.051; Fig. 
3.5).   
 At D8, the proportion of dogs with protective titers equaled 96% (45/47) without 
differing between dog groups (p=0.5; Fig. 3.5). Two dogs vaccinated 1-2 years before the 






Figure 3.6. Proportion of dogs presenting protective antibody titers (≥0.5 IU/ml) before (D0) and after 
(D8) rabies booster vaccination in function of time span since last vaccination (>1-2 years; >2-3 years; 
>3-7.5 years). No anamnestic response differences were found between groups (p=0.5).   
3.4.4. Vaccination compartmental model   
 In case of vaccination stop (scenario1), the proportion of immunized dogs drops in 
function of canine turnover rate. By considering an initial proportion of immune dogs of 80%, 
the critical threshold of 40% would be reached after 27 months in low risk and low turnover 
(17%) populations whereas a high risk and high turnover (36%) population would reach the 
threshold after 18 months. By considering an initial protection of 60%, the 40% threshold 
would be respectively reached after 15 and 10 months (Fig. 3.7).  
 
Figure 3.7. Effect of dog turnover rate on rabies vaccination coverage in absence of yearly vaccination 
campaigns. The model predicts the time (in months) needed for waning of rabies herd immunity below 
the critical threshold of 40% considering an initial herd immunity of 80% or 60% and a dog turnover 
rate of 17 or 36%. 
 When vaccinating systematically 80% of puppies at 3 months of age, the initial 
coverage of 60% remained above the threshold control in both low and high dog turnover 
populations. By considering an initial coverage of 24% (observed rate in Kinshasa), the 
critical (40%) and control (60%) thresholds would be reached respectively within 13 and 73 
months in high turnover population and within 19 and 80 months in low turnover population. 
By considering an initial coverage of 0%, both thresholds would be reached respectively after 
25 and 86 months in high turnover population whereas 37 and 98 months would be required 





Figure 3.8. Impact of systematic vaccination of puppies (at 3 months of age) in (a) low and (b) 
high dog turnover populations with initial vaccination coverage of 0%, 24% (coverage 
recorded in high risk populations in Kinshasa; Kazadi et al., 2020) or 60%. The vaccination 
success rate () was 90. 
 When 80% of juvenile dogs (3-12 months) are vaccinated each 6 months, the initial 
coverage of 60% remains above the critical threshold in both low and high dog turnover rate 
populations. By considering an initial coverage of 24% (observed rate in Kinshasa), the 
coverage increase gradually and reaches the critical threshold (40%) respectively within 31 
and 37 months in low and high turnover populations. By considering an initial coverage of 
0%, the coverage reaches the critical threshold after 49 months in both low and high turnover 





Figure 3.9. Impact of biannual pulse vaccination of juvenile dogs (3-12 months) in (a) low 
(17%)  and (b) high turnover rate population (36%) with initial vaccination coverage of 0%, 
24% ((coverage recorded in high risk populations in Kinshasa; Kazadi et al., 2020) and 60%.  
3.5. Discussion 
 The present study aimed at proposing a risk-based vaccination scheme by considering 
(i) the dynamics of canine populations with different risk profiles for rabies transmission and 
(ii) the efficacy and duration of a serologically-detectable immunity in response to 
vaccination and revaccination tested under field conditions. 
 The turnover rate was used as the main indicator of dog population dynamics. Indeed, 




kinetics. However, as new dog-owning households in surveyed areas were not included in the 
study, the turnover rate could be slightly underestimated.  
 Our study evidenced the link between the dog-keeping practices and the turnover rate. 
It was high (36%) in area with high roaming activity (>75% of dogs are free-roaming) and 
low (17%) in low roaming activity (25% of dogs are free-roaming). Similar differences were 
found for birth rates (45% versus 32%) and disappearance rates (40% versus 9%). Indeed, in 
high roaming population, dogs were free to mate, whilst most of them were not castrated or 
spayed. In addition, juvenile and adult dogs were in danger of being stolen or sold to the dog 
meat consumers. The mortality of puppies before weaning was also high. Similarly, high 
turnover rates of 37% and 50% were reported in settings with high roaming dog activity, 
respectively in Tunisia and Kenya (Seghaier et al., 1999; Kwoba et al., 2019). In contrast, the 
low turnover rate (17%) estimated in low roaming activity settings was close to the average 
turnover rate of 20% reported in Europe and North-America where good dog-keeping 
practices are observed (Jibat et al., 2015).  
 The primo-vaccination success rate and duration of a serologically-detectable 
immunity in response to revaccination were two jointly addressed topics for answering the 
following research question: “is the single vaccination sufficient to provide a lifetime 
protection against rabies?” Indeed, beside the turnover rate, the vaccine characteristics such as 
its ability to provide a lifetime protection was a key parameter of our vaccination model as 
discussed below. Our results showed that regardless of the age groups and prevaccinal titers, 
the vaccine was effective in 98% (81/83) of vaccinated dogs. Surprisingly, 47% (39/83) of 
dogs possessed prevaccinal protective titers (≥0.5 IU/ml). Similarly, in Tunisia and Brazil, 
were respectively 32% and 42% of dogs with unknown historical of vaccination had 
protective titers (Seghaier et al.,1999; Fernades et al., 2017).  
 In our study, the origin of prevaccinal antibodies should be clarified in order to avoid 
biased calculation of the vaccination success rate, mainly in puppies (≤3 months). It is highly 
likely that owners did not report the true vaccination status of their dogs given that the 
vaccine was gratuitous, whilst it cost up to 20 USD (Kazadi et al., 2017). This may explain 
the origin of prevaccinal protective titers mainly in juvenile and adult dogs. But, in puppies of 
less than 3 months of age, anti-rabies antibodies may originate either from their mother or 
from previous vaccination. Antibodies may also originate from rabies infection. This 




the paired blood collection period (day 0 and 30). It is likely that puppies (2-3 months of age) 
with prevaccinal protective titers were previously vaccinated against rabies. There are three 
givens in this argument: (i) the age of puppies (2-3 months), while it is established that 
maternally-derived antibodies decline significantly from weaning (10 weeks of age) (Day et 
al., 2016), (ii) the high serologically vaccination success rate of 100% (12/12), while it is 
assumed that high level of maternal antibodies hamper antibody production and (iii) the 
strong post-vaccination response (titers: 3.4 to 10 IU/ml), although high prevaccinal titers that 
ranged from 0.5 to 4.7 IU/ml (Table S3.1). Other serological studies reported the proportion 
of 23% to 26% respectively in Bhutan and Tunisia, but without providing the antibody origin 
(Seghaier et al., 1999; Yangchen et al., 2019). In Sir Lanka, none of clearly identified puppies 
(1.5-3 months) from vaccinated dams had prevaccinal protective titers (Pimburage et al., 
2017). In brief, our vaccination was considered as booster vaccination for 50% (12/24) of 
puppies with prevaccinal protective titers, whereas it is considered as primary-vaccination for 
other 50% (12/24) of puppies without prevaccinal protective titers. Thus, the assessment of 
vaccine efficacy in terms of serological response to primo-vaccination showed that the 
vaccination success rate was 92% (11/12). One puppy failed to seroconvert for unknown 
reason. The success rate ranging from 78% to 100% was reported in puppies by other 
serological studies (Cliquet et al., 2003; Kennedy et al., 2007; Morters et al., 2015; Wallace et 
al., 2017; Tasioudi et al., 2018). 
 It is important to note that the serological vaccination success rate is strongly 
associated to the time span between vaccination and blood test, the composition of vaccine 
used (antigen content, adjuvant used, mono or polyvalent ) and it storage conditions (Zanoni 
et al., 2010; Kennedy et al., 2007). It was reported that the primo-vaccination success rate is 
usually above 92% when blood was collected within 1 to 2 months after vaccination and 
drops up to 78% when antibodies are quantified 6 months after vaccination (Cliquet et al., 
2003; Minke et al.,2009; Van Gucht et Le Roux, 2010; Pimburage et al.,2017). In addition, 
when rabies vaccine is administered in conjunction with core vaccines (polyvalent vaccines), 
the success rate ranges from 78% to 91%. But when used as monovalent vaccine, its 
serological success rate is above 93% (Cliquet et al., 2003; Van Gucht et Le Roux, 2010). 
Furthermore, inactivated and adjuvanted (aluminum salts) rabies vaccines such as Rabisin 
(1IU/ml, Merial) provided a high success rate (≥96%) including in puppies (Minke et 
al.,2009, Morters et al.,2015, Nokireti et al.,2017, Yangchen et al.,2019). However, these 




adjuvant (aluminum salt) precipitates and thereby loses efficacy (Kartoglu and Milstien, 2014; 
Kumru et al., 2014). In contrast, a field study demonstrated that inactivated and adjuvanted 
vaccine (Novibac, Intervet) provided a similar vaccination success rate when it was stored at 
room temperature (up to 30
o
C) during several months, as when it was stored as recommend 
by manufacture (2 to 8
o
 C) (Lankester et al., 2016). Thus, in order to reduce potential biases 
associated with storage conditions, the vaccine used in the present study (Rabisin, Merial) was 
purchased in drugstore (D) into which the vaccine was relatively-well stored according to 
manufacture advices (2 to 8
o
 C) (Fig. S3.1). Taken together, above evidences strongly suggest 
that using a good quality vaccine may provide a serological success rate of at least 90% in 
puppies of below 3 months of age. 
 Furthermore, there is a conflict between regulation of some countries and scientific 
evidences about the duration of immunity provided by rabies vaccine in dogs. Indeed, in some 
countries such DRC, annual revaccination of dogs against rabies is still mandatory (Arrêté 
N
o
SC/151/BGV/MIN/AGRI & DR/SMI/2016) assuming that the duration of immunity last 
about 1 year, whereas in other countries where the law was modified or updated, 3 years is the 
minimum duration of immunity provided by the same vaccine such as Rabisin (Day et al., 
2016). Our results suggest that the duration of immunity provided by inactivated vaccine 
(Rabisin) last up to 3 years given that 96% (45/47) vaccinated since >1 to 7.5 years, display a 
rapid and strong serological response within 5 to 8 days upon revaccination. Only small 
number (2) of dogs did not display a rapid serological response within 5-8 days (Table S3.2). 
There are two possibilities: either these dogs were not previously vaccinated (Brown et al., 
2016) or they were vaccinated in spite of slow serological response. Our results are in line 
with other several serological and challenge studies which reported that the duration of 
immunity provided by rabies vaccine could last between 3-7 years in dog and up to 14 years 
in humans (Lakshmanan et al.,2006 ; Schultz, 2006 ; Roth and Spickler, 2010;  Malerczyk et 
al., 2007; Moore et al.,2015; Day et al.,2016).  
 Our study highlighted that rabies vaccine is effective in puppies of below 3 months of 
age and that it provides a long-term protection (≥ 3 years). However, these results may not 
directly lead to conclude that a single vaccination provides a lifetime protection, hence the 
reference to other studies. Précausta et al. (1985) evidenced that the protection against a 
pathogenic strain of rabies virus was excellent (97%) 3 years after a single vaccination. 
Lakshmanan et al. (2006), demonstrated that 88% of vaccinated once at 3 months of age with 




African wild dogs, anti-rabies antibodies were still detectable over 3 years after the single 
vaccination (Connolly et al.,2015). Aubert (1992) claimed that the survival chance against a 
pathogenic strain of rabies virus was the same for dogs with detectable or no detectable 
neutralizing antibodies at moment of challenge, provided that dogs without detectable 
neutralizing antibodies had successfully seroconverted after vaccination. Therefore, reassured 
by above evidences and the short life expectancy of observed dog populations (≤3 years for 
75%) as in most of African countries (Jibat et al.,2015), we suggest that a single dose of a 
good quality of rabies vaccine provides a life protection. This key evidence is the core 
parameter of vaccination strategy based on the systematic vaccination of puppies at weaning 
age (≥2 months) as discussed below. 
 Despite demonstrated positive impact of regular annual mass vaccination strategy for 
rabies control and elimination (Kitala et al., 2002; Hampson et al. 2007, Hampson et al.,2009, 
Global Alliance for Rabies Control, 2015), its implementation in rabies endemic countries is  
challenged by several factors such the lack of adequate resources. Yet, it appears that the risk 
of rabies transmission varies within settings or towns (Kazadi et al., 200), thereby making 
high risk zones as high-priority settings for action against rabies. This is the first level of 
improving the efficiency of vaccination program.  
 By modeling the vaccination scheme, two coverage thresholds: 40% considered as the 
critical threshold under which large rabies outbreak may occur in dog population (Coleman & 
Dye, 1996; Hampson et al.2009) and ≥60% referred to a threshold for effective rabies control 
(Cleveland et al., 2003; WHO, 2013). In particular, the critical threshold was used as a 
reference point for determining the frequency of mass vaccination campaign in low and high 
risk zones. Thus, by considering the turnover rate, when the initial coverage is 80%, the mass 
vaccination campaign may be implemented no more each 1.5 years in high risk and turnover 
rate (36%) population, whereas its can be safely implemented each two years (biennial) in low 
risk and low turnover rate (17%). With a free of charge mass vaccination campaign and 
community support, the vaccination coverage of 80% is reachable as reported in Zambia, 
Chad, Tanzania and Indonesia (Debalogh et al., 1993; Kayali et al.,2003; Kaare et al.,2009; 
Léchenne et al., 2016; Arief et al.,2017). Furthermore, our study confirming clearly the 
influence of turnover rate on kinetic of coverage and therefore the frequency of mass 
vaccination. Thus, ignoring the influence of turnover rate may lead to non-effective 
vaccination program. This was the case in Tunisia where without taking account of turnover 




from 1982 till 1992. However, six year later (1988), large rabies outbreaks occurred and the 
country decided to abandon biennial scheme in favour of annual mass vaccination campaigns 
(Seghaier et al., 1999). Notwithstanding this example, the biennial scheme may be 
implemented in low risk and low turnover rate population (≤17%) and may provide monetary 
savings ranged from 32 to 42% (Bilinski et al. (2016). Although the biennial scheme seems 
theoretically efficient, it cannot be safely implemented in most of urban and rural settings in 
endemic countries due to high turnover rate as the consequence of poor dog-keeping practices 
and poverty (Seghaier et al., 1999; Kwoba et al., 2019; Kazadi et al., 2020). 
                                                                                                                                                                                                                                                                                                                      
 In these poor and high risk zones, we propose the systematic vaccination of puppies at 
weaning (2-3 months of age), which is viewed as an alternative to the annual mass 
vaccination campaigns. Indeed, between two annual vaccination campaigns, the proportion of 
susceptible dogs mainly composed of puppies and juvenile dogs which were puppies at mass 
vaccination moments, may reach 50% (Fig 3.4) of dog population, thereby justifying the rapid 
decrease of coverage in high risk and high turnover rate (36%). Yet, vaccine is effective in 
puppies and provides a lifetime protection taking account the serological success rate of 
≥90%. These results constitute the first strong epidemiological reason to opt for systematic 
vaccination of puppies at 2-3 months of age. The model showed that the systematic 
vaccination of puppies (2-3 months of age) prevents the decrease of initial coverage. To the 
contrary, it contributes to gradually growth of coverage. Ideally, this scheme must be 
implemented after a mass vaccination campaign. In the extreme case (no financial resources 
for mass vaccination implementation), the systematic vaccination of 80% of puppies will 
contribute to prevent large rabies outbreaks within 13 and 25 months by increasing initial 
coverage from 24% and 0% to 40% (critical threshold) in high risk and high turnover rate 
(36%) population.   
 The second epidemiological reason is the high accessibility of puppies for parenteral 
vaccination. Indeed, the accessibility is one of the success key of vaccination strategies, given 
that it is affected by several factors such as the dog–human relationships, the dog owner’s 
perception about vaccination and the distance between the vaccination posts and households 
(Kaare et al., 2009; WHO, 2013; Jibat et al., 2015; Gibson et al., 2016). Studies reported that 
15 to 40% of adult dogs are usually not bringing to vaccination posts either because they were 
aggressive or because they had run away (Lembo et al., 2010; Kayali et al., 2003; Minyoo et 




(≤3 months) usually remain near their homestead and seem therefore easy to catch and to 
handle to vaccination posts (Minyoo et al., 2015, Muthiania et al., 2015, Arief et al.2017). 
However, some dog-owners continue to perceive that puppies are too young to be vaccinated 
and could refuse to bring them to vaccination posts (Minyoo et al., 2015, Muthiania et al., 
2015, Kazadi et al., 2017; Kazadi et al., 2020). This great issue for the success of monthly 
systematic vaccination of puppies could be addressed by an appropriate advertising or 
awareness strategy, by the significant reduction of vaccination cost and mainly by boosting 
community engagement.   
 The third and last second reason is economic, based on assumption of economic 
benefits associated to inclusion of puppies in vaccination program (Kaare et al., 2009). 
Indeed, the average mass dog vaccination cost per dog is US$ 4.03 (Min: US$ 1.56- Max: 
US$ 11.33). It was estimated that more than 60% of the  mass vaccination campaign budget is 
spent on covering the vaccinator costs (perdiem, transportation…) given the time (1-3 
months) dedicated each year by  vaccinators for vaccination campaign (Kayali et al., 2006; 
WHO, 2013; Wallace et al, 2017,). We believe that given the small number of puppies aged 
of 3 months to be vaccinated each month , the rabies vaccination shall be easily integrated in 
routine activities of public animal health workers (veterinarians and para-veterinarians) which 
will dedicated just few days (1 or 2 days) for vaccination of available weaned puppies at low 
geographic levels. This vaccination strategy may theoretically provide monetary savings and 
seems to be more sustainable. However, due to poor veterinary infrastructures across the 
country, the storage of rabies vaccine could be a challenge (Niang and Denormandie, 2008; 
Diop et al., 2012; Ministère de la Pêche et de l’Elevage, 2017). This issue can be addressed 
through the intersectoral collaboration (One Health approach) between the Public health and 
Veterinary sectors given that most of health centers  are equipped with refrigerators and solar 
panels or fuels for good storage of human vaccines (PATH,2016). Conversely, the 
intersectoral collaboration it will be needed also for better assessment of the impact of this 
vaccination strategy on the rabies incidence.  
 Finally, the mandatory systematic vaccination of puppies at 3 months of age will be a 
great opportunity for gradual identification of dogs at the veterinary services as required by 
law since 1918 in DRC (Royal Decree of 22 January 1918). 
 Furthermore, the biennial pulse vaccination of juveniles (3-12 months) could be an 




impact the accessibility of puppies to parenteral vaccination or logistical challenges such the 
lack of cold chain for ensuring a good storage of vaccine. In addition, the biennial vaccination 
strategy may enhance the chance of catching up dogs that were not previously reached, 
contrary to the strategy of unique vaccination of dogs at weaning. However, only field cost-
effectiveness studies may help to determine the most cost-effective vaccination strategy for 
resource-poor settings. 
3.5. Conclusion  
 The study evidenced the link between the dog-keeping practices and the turnover rate, 
which influences the coverage kinetics. Hence, the needs to put in place a setting-specific 
vaccination scheme. The turnover rate was high in high risk and high roaming dog population, 
thereby leading to rapid decrease of vaccination coverage. In contrast, in the same high 
turnover rate settings, when dogs are systematically vaccinated at 3 months of age), herd 
immunity is preserved even in high turnover areas, thereby confirming the epidemiological 
needs for inclusion of puppies in vaccination program. Theoretically, the systematic 
vaccination of puppies at weaning seems to be efficient and more appropriate rabies 
vaccination strategy for rabies control at source in resource-poor and endemic countries, 





















Chapter 4. Overview of the intersectoral collaboration in 




Understanding local epidemiological factors is a prerequisite to design the most appropriate 
and effective rabies control strategy. Local risk factors and risk zones were identified in our 
fist study (Chapter 2). Accordingly, the established risk zones were used in the development of 
a risk-based vaccination scheme that shall be supported by local rabies network for its 
success. The objective of this preliminary survey was to describe the existing rabies 
surveillance and control networks in DRC and to assess the level of interaction between the 
concerned professional sectors. The study revealed that institutions of the wildlife sector were 
not involved in rabies management, contrarily to medical and veterinary institutions which 
make up the rabies surveillance and control networks in DRC. Despite the fact that medical 
and veterinary institutions are implanted across the country, the study showed that the 
collaboration between them was inadequate at operational and strategic levels. The 
structural weaknesses and the lack of political will have emerged as the main causes of the 









4.1. Abstract  
 Rabies is endemic in Democratic Republic of the Congo (DRC). As it is a zoonosis, its 
control requires a strong and effective intersectoral collaborative approach, which may 
contribute to a more efficient use of available resources. The objective of this preliminary 
survey was to describe the existent rabies network in DRC and to assess the level of 
interaction between sectors using the stakeholder analysis method. A total of 17 institutions 
including governmental (public) and non-governmental (professional bodies and international 
agencies) institutions that were assumed to be involved in rabies management in DRC were 
considered. Governmental institutions were national and subnational institutions of medical, 
veterinary and wildlife sectors. Fifteen key informants from 15 institutions were available to 
participate in the study and were interviewed. All key informants had a good understanding of 
One Health. They stated that intersectoral collaboration between medical, veterinary and 
wildlife sectors is the right approach for rabies management in DRC. The study highlighted 
the fact that institutions of wildlife sectors are not involved in rabies network in DRC, mainly 
because of the lack of surveillance system of wildlife diseases. The rabies network is made up 
mainly of institutions of medical and veterinary sectors. However, the collaboration between 
medical and veterinary sectors is weak, despite the existence of human and animal disease 
surveillance systems and the countrywide implantation of medical and veterinary institutions. 
Resources and data are not shared between both sectors either because they are not available 
or due to the lack of legal collaborative framework. The structural weaknesses and the lack of 
political will have emerged as the main barriers to strong collaboration among stakeholders 
that are involved in rabies management in DRC. However, a further study with a wider range 
of stakeholders and respondents should be conducted in order to reach the sampling saturation 












 Rabies is endemic in Democratic Republic of the Congo (DRC) and in all bordering 
countries namely Angola, Burundi, Central African Republic, Republic of Congo, Rwanda, 
South Sudan, Tanzania, Uganda, and Zambia (Repetto, 1932; Courtois et al., 1964;, 
Makumbu, 1977; Georges, 1982; Bula and Mafwala, 1988; Swanepoel et al., 1993; Ali, 2002; 
Muyila et al.,2014; Twabela et al., 2016; Pieracci et al., 2017; Muleya et al., 2019). In 
addition, it is a zoonosis, that infects all mammal species including humans (Rosset, 1985). 
Thus, its control requires an intersectoral collaboration (Léchenne, 20015). 
 In light of the above, we propose this preliminary survey that aimed at describing the 
existent rabies surveillance and control networks in DRC and assessing the interaction level 
between sectors or institutions using the stakeholder analysis method.  
4.3. One Health and stakeholder analysis   
 One Health is a strategic framework for reducing risks of infectious diseases at the 
animal-human-ecosystem interface by promoting the cooperation, communication and 
coordination among sectors or areas of expertise (Mackenzie and Jeggo, 2011). It is also 
promoting the use of available resources by integrating the disease control strategies (FAO, 
2014). Yet, rabies is a zoonotic disease requiring the collaboration between actors or sectors 
for an efficient control (Léchenne, 2015). These actors can be also called stakeholders, a term 
that, in a One Health framework, may cover the ultimate beneficiaries (human, animals and 
environment) as well as the governmental and non-governmental organizations (government 
ministries, research institute, professional bodies, civil society, local and international 
agencies) that work to protect them against diseases (Mazet et al.,2014). More widely 
speaking, stakeholders may be considered as anyone who impacts a project or is impacted by 
this project. 
 Furthemore, the stakeholder analysis consists of methods allowing to (i) identify 
stakeholders, (ii) categorize stakeholders, and (iii) investigate relationships between 







4.4. Preliminary survey   
 This preliminary survey was carried out from April to May 2017, in Kinshasa, the 
capital of DRC that hosts subnational (provincial), national and international institutions. 
Indeed, Kinshasa is simultaneously a Province and the capital of DRC. The stakeholder 
analysis method was used but limiting the stakeholder concept to formal organizations that 
were assumed to be involved in the rabies management in DRC. These could be subnational 
(provincial) and national governmental institutions and local or international non-
governmental institutions. The first listed stakeholders were governmental institutions that 
belong to the medical, veterinary and wildlife sector. Then, non-governmental stakeholders 
were listed through the snowball sampling method, which is a convenience sampling method 
for finding research subjects in a context were no exhaustive list of potential interviewees 
with their relevant characteristics are available. Starting from first key-informants, each 
interviewee will propose to the research team other potential stakeholders according to their 
understanding of the research question and their knowledge of the relevant actors. Sampling 
continues until data saturation (Naderifar et al., 2017). In the present case, this survey being 
preliminary, no saturation was sought and for each stakeholder listed, one key informant was 
identified and contacted by phone to make an appointment for the interview.  
 The role of stakeholders in relation with rabies and their perceptions about One Health 
were collected through semi-structure interviews, guided by a check-list (S4.1). The semi-
structured interview is a qualitative method that needs a trust-based relationship between the 
investigator and the interviewed (Imbert, 2010). The interview tacked the actor’s perception 
about the OH approach, the motivation, the predisposition to work in collaboration with other 
sectors and the possible challenges. The check-list included the following items: (i) the 
institution role in relation to rabies management, (ii) the rabies control actions taken, (iii) 
understanding of OH approach, (iv) involvement in OH approach and difficulties or 
challenges encountered, (v) OH initiatives taken in relation with rabies, (vi) proposed 
strategies for making the OH approach a reality in the rabies management, and (vii) 
expectations from implementation of OH approach. Key informants responses were 
summarized in a table.   
 The status and level of collaboration between stakeholders in relation with rabies 
management, was assessed (Table 4.1), based on a grid covering on key elements of effective 




Health Organization for Animal Health (OIE) and World Health Organization (WHO) 
(FAO/OIE/WHO, 2012). This tool included nine key elements that were divided in supporting 
and operational elements. These include : (i) availability of the intersectoral rabies program, 
(ii) availability of the legal collaborative framework  (iii) data sharing, (iv) human resource 
sharing, (v) material sharing, (vi) financial resource sharing, (vii) organization of 
multisectoral workshop, (viii) joint planning of rabies control activities, and (ix) joint 
implementation of rabies control activities. The first two elements were supporting elements 
and considered as key elements. They were binary variables (yes/no). The last seven key 
elements were operational criteria. They were also binary variables (yes/no). In case of 
existing collaboration, the frequency of collaboration was specified. This frequency was 
graded as (i) regular, (ii) irregular or (iii) rare. Based on these criteria, four possible levels of 
interaction were established between the three public major stakeholders: (i) strong interaction 
(ii) moderate interaction (iii) weak interaction and (iv) no interaction. Finally, a relational 
diagram was developed based on the level of interaction between stakeholders. This 
assessment of level of collaboration was particularly focused on governmental stakeholders.  
 In particular, with the purpose of assessing the data-sharing between sectors, reported 
and notified rabies data were compared. “Reporting is the act of a clinician /veterinarian 
/laboratory informing the local health/veterinary agency of a suspected or confirmed case of a 
disease. Notification is the process of the local health/veterinary agency informing the 
national health/veterinary agency and to the relevant international organizations such as 
World Health Organization (WHO) and World Health Organization for Animal Health (OIE)” 











Table 4.1. The ranking table of interaction level between stakeholders which are supposed to 
be involved in the rabies management in DRC   
N
0
 Key elements  Interaction level ranking 
Strong Moderate Weak Non-existent 
1 Availability of the  intersectoral rabies 
programme 
Yes Yes No No 
2. Availability of the legal collaborative 
framework  
Yes Yes No No 
3. Data sharing Yes/regular Yes/irregular Yes/rare No 
4. Human resource sharing Yes/regular Yes/irregular No No 
5. Material sharing Yes/regular Yes/irregular No No 
6. Financial resource sharing Yes/regular Yes/irregular No No 
7. Organization of multisectoral workshop Yes/regular Yes/irregular Yes/rare No 
8. Joint planning of rabies control activities Yes/regular Yes/irregular Yes/rare No 
9. Joint implementation of rabies control 
activities  
Yes/regular Yes/irregular Yes/rare No 
 
4.5. Main observations 
 Seventeen governmental and non-governmental organizations that were assumed to be 
involved in rabies management in DRC were listed. Two were not available for interviews ( 
country office of the WHO and the municipality of Kinshasa). 
 In relation with rabies, stakeholders of the veterinary sector (5) perceived their role as 
that of surveillance and control of rabies in domestic animals on the one hand, and that of 
prevention of human rabies (treatment of bite victims) on the other hand. Stakeholders of 
medical sector (3) described their role as one of surveillance and prevention of rabies in 
humans. Stakeholders of wildlife sector (2) reported having no role in the control of rabies. 
Furthermore, both animal health professional bodies stated that their role was limited to 
encourage their members (veterinarians and paraveterinarians) to participate in rabies control 
activities. Interviewed international agencies (FAO, OIE, CDC) claimed to provide technical 
support to governmental institutions which are involved in rabies control (Table 4.2). 
All key informants from listed subnational and national governmental institutions (10) 
had a good understanding of the One Health approach. They claimed that OH approach was 
the only way for the control of zoonotic diseases such as rabies. However, in practice did not 
work collaboratively for rabies control, except some rare activities. They argued that the lack 
of legal collaborative framework, the lack of logistic and financial resources and the lack of 
surveillance system (as stated particularly by the wildlife institutions) were the main barriers 




medical and veterinary sectors was particularly mentioned by veterinary sector as another 
barrier against the intersectoral collaboration. They think that political will is the only way to 
make the OH approach a reality. The expectations were the creation of a national program for 
the fight against zoonotic disease, the capacity building of medical, veterinary and wildlife 
workers and surveillance systems and the standardization of rabies data collection tools 
(Table 4.3). 
 
Table 4.2. Role of institutions supposed to be involved in the rabies management in DRC  
N
0
 Institution Role in relation with rabies  
Veterinary  sector 
1 Direction de Production et Santé 
Animale (DPSA) 
Planning and implementation of rabies activities in animals across the 
country 
2 Service Quarantaine Animale et 
Végétale (SQAV) 
Checking  rabies vaccination certificate of pets at borders  
3 Laboratoire Vétérinaire (LVC) Diagnosis of animal rabies cases 
4 Bureau Provincial de Santé 
Animale (BPSA) 
Planning and implementating of rabies activities at rovincial) level 
5 Office de vaccination et de contrôle 
rabique (OVCR) 
Treatment of human bite victims  
Tracing of suspected animal rabies cases 
Supervision of mass vaccination campaigns 
Medical sector 
6 
Direction de Lutte des Maladies 
(DLM) 
Rabies surveillance (national level) in humans 
Treatment of human bite victims  
7 Institut National des Recherches 
Biomédicales (INRB) 
Diagnosis of human and animal rabies cases 
8 Bureau de surveillance (B4) Rabies surveillance (local/provincial) level 
Treatment of human bite victims 
 Environnement/Wildlife health sector 
9 Institut Congolais pour la 
Conservation de la Nature (ICCN) 
Management of wildlife animals in protected areas   
10 Direction de Conservation de la 
Nature (DCN) 
Management of wildlife animals in unprotected areas 
Professional bodies  
11 Association des Médecins 
Vétérinaires du Congo (AMVC) 
Encourage veterinarians to join in fighting against rabies in the country 
12 Association des techniciens 
vétérinaires du Congo (ATVCO)  
Encourage paraveterinarians (veterinary nurses) to join  in fighting against 
rabies in the country 
 International agencies  
13 Food and Agriculture Organization 
(FAO) 
Technical support of public institutions  
 
14 World Organization for Animal 
health (OIE) 
Collecting, analyzing and disseminating national rabies data   
15 Centers for Disease Control and 
Preventions (CDC) 
Financial and technical support of the field epidemiological and training 






Table 4.3.  Key informant perceptions of OH approach  
N0 Institutions  Understanding of OH 
approach 
Involvement in OH approach 
and challenges encountered  
OH initiatives taken  in 
relation with rabies  
Proposed strategies for  making 
the OH approach a reality  
Expectations from 
OH approach  
1 DPSA This approach ensures 
that each actor of 
network  plays its role in 
collaboration with other 
actors 
My institution is a member of 
the national One Health 
committee.  But, with respect 
to rabies, no action has been 
taken due to lack of financial 
resources. 
No OH initiative in relation 
with rabies has been taken. 
Funding of OH committee and 
providing a legal framework for 




awareness for their 
specific role. 
2 LVC Integral application  of 
prevention, detection and 
response against 
zoonotic diseases by 
involving medical, 
veterinary and wildlife 
sectors 
Yes Rare meetings held at DLM 
and planning rabies mass 
campaigns. 
 
Creation of a legal collaborative 
framework for all actors 
involved in rabies management 
that establishes duties and 
responsibilities of actors. 
Extension of legal 
collaborative 
framework for rabies 




3 SQAV The fight against rabies 
must include experts 
from medical, veterinary 
and wildlife sectors, dog 
owners and  policy 
makers 
My institution is theoretically 
involved in OH. But, in 
practice, each institution 
works in vacuum, whereas 
normally results and actions 
should be shared among actors  
Rare OH initiatives such as 




institutions requires first of all a 
political will. Then, the creation 
of a multidisciplinary 
institution like the national 
program to combat rabies. 
Creation of a 
multidisciplinary 
institution like the 
national program to 
combat rabies 
4 BPSA Close collaboration 
between medical and 
veterinary structures. 
Yes, but with major 
difficulties such as: leadership 
conflict between medical and 
veterinary actors, lack of 
financial resources and 
structural collaborative 
framework.  
Jointly planning with medical 
sector of mass vaccination 
campaign in Kinshasa. 
Creation of a multidisciplinary 
structure called national 
program for fight against 
zoonosis. This program must be 
lead by the veterinary sector 
given that animals are the main 
source. 
Creation of a 
multidisciplinary 
structure called 
national program for 
fight against zoonosis. 
Abbreviations: Direction de Production et Santé Animale (DPSA), Laboratoire Vétérinaire Central (LVC), Service de Quarantaine Animale et Végétale (SQAV), Bureau de 





N0 Institutions  Understanding of OH 
approach 
Involvement in OH approach 
and challenges  encountered  
OH initiatives taken in 
relation with rabies 
Proposed strategies for  making 
the OH approach a reality  
Expectations from OH 
approach  
5 OVCR A new spirit that put 
together experts from 
several fields for control 
of zoonosis. 
Yes, but with major financial 
and logistic difficulties  
OVCR was created in 
response to intersectoral 
to meet a need for 
integrated rabies control. 
Creation of national program for 
rabies control that must ensure 
an open and sincere 
intersectoral collaboration and 
provide personal capacity- 
building. 
Collaboration between 
medical and veterinary 
sector for rabies control. 
6 DLM Multidisciplinary, 
intersectoral and 
collaborative approach 
that addresses risks at 
human, animals and 
wildlife interfaces. 
There is no formal OH team. 
Our institution works 
informally with veterinarians  
if zoonotic epidemics occur 
such as during the avian 
influenza outbreak in 2003. 
Jointly planning with 
veterinary sector of mass 
vaccination campaign of 
pets. 
 
Creation of a legal collaborative 
framework between medical, 
veterinary and wildlife sectors. 
Creation of a legal 
collaborative framework 
between medical, 
veterinary and wildlife 
sectors. Harmonization of 
rabies data collection tools  
7 INRB Human health is closely 
linked to health of pets 
such as rabies. 
No.  Communication and 
funding gaps 
My laboratory includes 
veterinary and medical 
workers.. 
Support the surveillance and 
control of rabies in animal 
population. 
Support the intersectoral 
collaboration to ensure that 
human and animals are 
healthy. 
8 B4 Close collaboration 
between medical and 
veterinary structures for 
control of zoonotic 
diseases. 
No.  Jointly creation of rabies 
task force in 2012 which 
is not functional. 
Institutionalization of rabies 
control at the highest level of 
the state. 
Promotion of collaboration 
between medical and 
veterinary sectors. 
9 DCN Prevention, detection and 
response to rabies require 
involvement of all actors. 
Yes We are in an embryonic 
stage in relation with 
disease surveillance and 
control activities. 
Implementation of data flow 
system  
Wildlife sector is less 
involved in health 
activities. OH approach is 
an opportunity for capacity 
building of actors of 
wildlife sector. 
10 ICCN Rabies affects human, 
pets and wildlife, hence 
the interest of having 
human, animal and 
wildlife rabies 
surveillance systems. 
Yes No Intensification of the contacts 
between stakeholders in order to 
determine how to improve the 
management of rabies.  
Revitalization of the 
national One Health 
committee. 
Abbreviations: Direction de Production et Santé Animale (DPSA), Laboratoire Vétérinaire Central (LVC), Service de Quarantaine Animale et Végétale (SQAV), Bureau de 
Production et Santé Animale (BPSA), Office of vaccination and rabies control (OVCR), Direction de Lutte contre la Maladie (DLM), Institut National de Recherche 




According to criterion for assessing the level of collaboration across sectors (Table 




 criteria were rarely met by medical and veterinary institutions. The 
following jointly activities were: (i) the establishment of One Health rabies task force in 
Kinshasa which is non-operational, (ii) the organization of multidisciplinary workshop on 
rabies that has been initiated by the Food and Agriculture Organization (FAO, 2012), (iii) the 
planning of rabies mass vaccination campaign of pets, and (iv) the holding of a formal weekly 
multisectoral surveillance meeting at local and central levels by medical sector (Table 4.3). 
The relational diagram (Fig 4.1) showed that the wildlife health sector was completely 
disconnected from both medical and veterinary sectors regarding rabies management. In 
contrast, the collaboration between medical and veterinary sectors was weak or inadequate.  
No data-sharing was noted between institutions of wildlife health sectors. Rabies data 
were regularly shared inside institutions of medical and veterinary sectors according to data 
flow (Fig. 4.1), except, the “Service de Quarantaine Animale et Végétale (SQAV)”. This 
institution which belongs to the veterinary sector is particularly involved in rabies control at 
border crossing through the control of rabies status of pet animals. The comparison data on 
human bite victims and human clinical rabies cases reported from 2013 to 2016 by the 
“Bureau Provincial de Santé Animale (BPSA)” (veterinary sector) and the “Bureau de 
surveillance (B4)” of medical sector revealed the discrepancy between data reported by both 
provincial institutions (Fig. 4.2). The figure S4.1 shows the flow data in medical and 







Figure 4.1. The interaction between the stakeholders of governmental (public) sector of DRC. An 
arrow was associated to each level of interaction: (i) continue arrow (strong interaction), (ii) 
dotted arrow (moderate interaction) and (iii) broken arrow (weak collaboration). Inside the 
sector, a continue double headed arrow indicates the rabies data-sharing. 
 
 
Figure 4.2. Reported (a) human bite victims and (b) human rabies cases from 2013 to 2016 by two 




4.6. Discussion and perspectives  
This preliminary survey revealed that the One Health concept was not a new concept 
for governmental stakeholders. However, its application in relation with rabies management 
was still a theory given the lack or low level of collaboration between these governmental 
stakeholders (Fig. 4.1). Several factors would contribute to limit the translation of the One 
Health concept from theory to practice. They can be grouped in two categories: structural and 
political constraints. They are discussed below.  
According to expert opinions, the data-sharing between sectors is the crucial factor for 
success or failure of a OH initiative (Cleaveland et al., 2014, Global Alliance for Rabies 
Control, 2015; Rüegg et al., 2018). This preliminary survey showed a lack of sharing and 
harmonization of rabies data between the medical and veterinary sectors (Fig 4.2), 
notwithstanding the fact that the medical sector holds weekly multisectoral surveillance 
meetings at local and national levels, which can be considered as a framework for sharing 
rabies data. The lack of legal collaborative framework was reported by stakeholders as the 
main reason. We think that beside the lack of legal collaborative framework, the structure and 
functioning of medical and veterinary surveillance systems (Fig. S4.1) could contribute to 
lack of data-sharing. Both factors could be considered as structural factors. 
Indeed, in DRC, the veterinary sector must report both animal and human rabies data 
according to reported role of this sector in rabies control. All biting or suspected rabid animals 
(pet animals) should be placed in quarantine for 21 days in public pounds. Unfortunately, they 
are not usually isolated either because the information is not relayed to local veterinary 
service on time or due to lack of appropriate infrastructures (pounds) for the animal isolation. 
As an alternative, a weekly close home-based follow up of biting pet animals may be applied 
by official veterinarians. These animals are euthanized (poisoned) once clinical signs of rabies 
occur. But, at the grass root level, there are no adequate logistical resources for collection, 
packaging and shipping of samples to veterinary laboratories. In addition, the country has 
only 3 veterinary laboratories located in 3 Provinces (Kinshasa, Haut-Katanga, Nord-Kivu), 
while DRC is a huge country made up of 26 Provinces and with poor infrastructures. We must 
note that rabies sample analysis including the trepanation for collection brain sample costs 
between 50-100 USD. Taken together, above reasons explained why few animal laboratory 
rabies data are available. For example, from 1980 to 2017, the Central Veterinary Laboratory 




samples. The public veterinary service had submitted only 30 samples during the same period, 
representing a low participation level of 12%, resulting in an annual average of 1 (Fig. S4.2). 
The average annual number of suspect animal samples submitted for laboratory rabies testing 
was extremely low compared to those annually analyzed in other developing and rabies 
endemic countries such as Kenya (128), Ethiopia (350) and Bolivia (392) (Widdowson et 
al.,2002; Deressa et al., 2010; Bitek et al., 2019). The poor performance of veterinary services 
was reported in a majority of Sub-Saharan African countries due to lack of financial resources 
since colonial era and structural adjustments periods (Sidibe, 2003; Niang et al., 2008; Diop et 
al.,2012; Bardosh et al.,2017; Ministère de Pêche et Elevage, 2017). Therefore, animal rabies 
data to share with other sectors are usually not available. 
On the other hand as mentioned above, the veterinary sector is generating human 
rabies data (Fig. S4.1a). Indeed, most of public veterinary clinics located in provincial capitals 
(Kinshasa, Kananga, Mbuji-Mayi,etc) had created formal (e.g. OVCR in Kinshasa) or 
informal rabies centers where human victims receive post-exposure prophylaxis (PEP).This 
PEP is administered by nurses or physicians, thereby making these formal or informal centers 
as illustration of multisectoral framework. However, rabies data are annually reported from 
bottom to the top of veterinary surveillance system jointly with other administrative reports of 
Ministry of Agriculture, Fisheries and Livestock, whereas in medical sector, data are weekly 
reported from bottom to the top of surveillance system (Fig. S4.1.b). This discrepancy in 
frequency of reporting data could be a major reason of lack of data-sharing, despite the 
existence of weekly intersectoral surveillance meeting organized by the medical sector.   
Furthermore, rabies data from medical sector are also under-reported due to 
inadequate surveillance system and lack of rabies centers across the country (Muyila et al., 
2014). Therefore, health facilities are the primary data collection sites of rabies data. Yet, 
30% of health facilities were not integrated into medical surveillance system. The case 
definition list of diseases with epidemic potential under surveillance was not available in 40% 
of health facilities. If it was available, the case definition of rabies was not yet included 
systematically given that rabies was just recently (2012) listed among disease under 
surveillance (Ministère de la Santé Publique, 2011 Kazadi, 2014; Ministère de la Santé 
Publique, 2017). The wildlife sector was not yet involved in rabies management because of 
lack of functional surveillance system. The priority of institutions of wildlife sector is the 
protection of wild animals against poaching (Ministère de l’Environnement et Développement 




The second constraint seems to be the lack of political will as reported by 
stakeholders. Indeed, DRC is a country with a strictly centralized administration. National 
ministries are the decision-making centers and they play a critical role in the formulation and 
implementation of policies for disease control. Thus the failure to take sufficiently into 
account the true rabies burden by high-level policy makers may contribute to a lack of 
political will in relation with rabies control. Accordingly, rabies is still officially ranked 
among Neglected Tropical Disease in DRC (Uniting to Combat NTDs, 2016). Indeed, it is 
well known that diseases are often prioritized according to those that are most visible or 
perceived as a public health threat. Failure to command attention leads to a lack of political 
commitment and resources required the implementing an effective elimination strategy. The 
lack of rabies data seems to be the fundamental challenge of rabies prioritization in most of 
Sub-Saharan African (SSA) countries (Fahrion et al., 2016; Canine Rabies Blueprint 2017; 
WHO, 2017; Scott, 2017; Taylor, 2017).  
As a direct consequences of this lack of political will in relation with rabies control, 
the disease is neglected (Uniting to Combat NTDs, 2016) and keeps killing mainly in poor 
settings where both veterinary rabies vaccine cost (20 USD) and post-exposure prophylaxis 
cost (350USD) are not affordable for majority of people who are mostly living under the 
poverty threshold in DRC (Moummi et al., 2010; Muyila et al., 2014; Bodjick,2016; Kazadi et 
al., 2017 ; Mpoyo et al.,2018; Kazadi et al., 2020). Yet, the close communication including 
data-sharing between the human and animal health sectors could significantly reduce the 
overuse of PEP (Lembo et al., 2010; Léchene et al., 2015). The country benefits from medical 
and veterinary structures which are well established in several parts. In addition, since 2005, 
the community-based surveillance of human diseases was implemented across the country 
(Mawazo, 2013).   
Yet, the political will may result in creation of a National Program for the Prevention 
and Fight against Zoonotic Diseases (NPFZD) by the Prime Minister decree as in some 
African countries such as Uganda, Nigeria and Cameroon where success stories were reported 
(Nzietchueng et al., 2013; Okello et al., 2014). It may also result in the establishment of a 
legal and mandatory collaborative framework at local and national levels. This program or 
legal framework should clearly define the role of each actor, the process and framework of 
sharing of data, human, material and financial resources and establish the chain of command 
(Bogel et al.,1992; Léchenne et al.,2018;). Hence, this would also appear as needed in the 




the program or legal framework provides opportunity for donor investments in rabies 
elimination (Global Alliance for Rabies Control), as is currently the case of several diseases 
such malaria, HIV/AIDS, tuberculosis, etc. 
 In conclusion, this preliminary survey highlighted that the rabies surveillance and 
control network in DRC is made up mainly of institutions of medical and veterinary sectors. 
Institutions of wildlife sectors are not included in rabies network. However, the collaboration 
between medical and veterinary sectors was weak, notwithstanding the existence of 
surveillance system of human and animal diseases. The structural weaknesses and the lack of 
political will have emerged as major barriers to strong collaboration among governmental 
stakeholders. However, a further study with a wider range of stakeholders and respondents 
should be made in order to reach the sampling saturation and to refine the present findings 
through the triangulation method. The future study must include (i) high political decision-
makers (ministries) as stakeholders in order to investigate reasons for the lack of political in 
relation with rabies control and (ii) research institute (universities), civil society, local and 
international non-governmental organizations for purpose of specifying the role of each one in 
rabies control in DRC. In addition, a field study should be conducted at area-scale in order to 
(i) assess the acceptability of the integrated approach for rabies prevention and control by the 
medical, veterinary and wildlife workers and the community, and (ii) assess the cost-







































This chapter discusses the key findings obtained from chapters 2, 3 and 4, which theoretically 
lead to improve the efficiency of rabies control program in poor resource settings. The 
strengths and weaknesses of each key finding are addressed.  
5.1. The epidemiological value of using the dog ecology survey as a tool for the field 
establishment of rabies risk map  
 The study highlighted that poor dog-keeping practices and low vaccination coverage 
were the main factors of rabies transmission in dog population. These factors may lead to the 
stratification of risk zones. They were estimated using the dog ecology survey method. Thus, 
it is important to establish the epidemiological value of this method as tool for the field 
establishment of risk map. 
 Dog ecology survey is thought to be useful estimate accurate data such as  the  human 
to dog ratio (HDR), dog density, age and sex structure of dog populations, dog keeping-
practices (dog roaming activity) and vaccination coverage (FAO, 2014). Different 
methodologies can be used to estimate these parameters: (i) mark-recapture, (ii) street-count 
method or direct observation of dogs on public properties, and (iii) household survey (WHO, 
1987; Kitala et al., 2001; Kayali et al., 2003; WSPA, 2007; Kazadi et al., 2020). 
 Household survey is more appropriate in areas where dogs are not registered by the 
national services (WHO, 1987) and where few numbers of free-roaming dogs are feral as 
reported in Zimbabwe, Tanzania, Chad and DRC (Butler and Binghame, 2000; Cleaveland, 
2014; Kazadi et al., 2020). Despite the fact that it generates accurate and useful data, it 
appears to be costly (Townsend et al., 2013). In DRC, the household survey can be 
transformed into relatively cheap method by involving existing volunteer community health 
promoters or “relais communautaires”. Investigators should visit dog-owning households 
between 8 am and 6 pm (lowest roaming time) in order to maximize the chance to see find 
dogs and collect accurate data on dog characteristics ( age, breed…) mainly in quartiers with 
high proportion of free-roaming dogs (WHO, 1987). Dog-owning households have to be 
selected randomly to achieve high representative level of the dog population in an area.  
 If these conditions are met, the household survey may help to estimate accurately the 
dog density, roaming activity and vaccination coverage of dog population, which are 
considered as risk factors of dog rabies transmission. Despite the controversy about the role of 






 in endemic regions of Africa (Foggin, 1988; Brooks, 1990, Cleaveland and Dye; 
1995; Kitala et al. 2002). The weight of dog density as risk factor of rabies transmission 
should be contextualized in combination with the data on dog-keeping practices (abundance 
of free-roaming dogs) given that both factors influence the contact rate (Kazadi et al.,2020). 
In contrast, there is evidence that the free-roaming associated with low vaccination coverage 
are risk factors for rabies transmission (Kazadi et al., 2020). Indeed, the absence of a physical 
barrier as illustrated in Fig. S2.1 evidenced that owned dogs are either partially or 
permanently free-roaming, that consequently increase their risk of coming into contact with 
rabid dogs. Once exposed (bitten by a rabid dog), the risk of developing rabies infection is 
very high for a dog especially if it is not vaccinated against rabies. However, the risk of rabies 
transmission in dog population depends on herd immunity; hence the existence of two 
coverage thresholds: 40% considered as the critical threshold under which large rabies 
outbreak may occur in dog population (Coleman & Dye, 1996; Hampson et al.2009) and 
≥60% referred to a threshold for effective rabies control (Cleveland et al., 2003; WHO, 2013). 
These coverage thresholds have been established either empirically from observations on the 
relationship between vaccination coverage and rabies incidence (Korns, 1948) or theoretically 
based on estimation of basic reproduction number of rabies (R0) (Coleman & Dye, 1996). 
They can be adapted according to local field data if the influence of the dog density and rate 
contact on the basic reproduction number of rabies is clearly established (Coleman & Dye, 
1996; Bengo et al., 2002).  In practice, the vaccination status of owned dogs may be 
assessed by considering owner’s report (history of vaccination and time of last vaccination) or 
the vaccination certificate (if available). In the absence of vaccination certificate, mis-
classification of vaccination status of dog may occur. On the one hand, people might fear to 
declare they owned dogs that were not vaccinated given that rabies vaccination is mandatory 
since 1938 in DRC (Royal Decree of 01 April 1938). On the other hand, dog owners may 
falsely report that their dogs are not vaccinated in order to benefit from gratuitous 
vaccination. Our serological results showed that only 9% (12/132) of reported vaccinated 
dogs for several years had no detectable anti-rabies antibody (0.18 IU/ml), further 
supporting the reliability of dog owner reports. 
 Based on these results, we strongly suggest the use of household survey for data 
collection to estimation of dog density, roaming activity and vaccination coverage. We also 
suggest the use of the developed tool for local risk assessment and risk zone stratification 




2.1). In addition, if data about dog bite or rabies incidence are available, they can be used for 
improving the stratification of risk zones. For instance, high risk zones are usually 
characterized by high abundance of free-roaming dogs and low vaccination coverage as the 
consequence of poverty (Kazadi et al., 2020). 
 Given the link established between the risk zones and their socio-economic levels, 
beside the household survey, it may be appropriate in the future to use geographic tools such 
as earth observation (EO), geographic information systems (GIS) and field observations of 
areas (different from household survey) for urbanization classification at area-scale and 
stratification of risk zones. For instance, the earth observation tool can help to map slum areas 
or the presence of solid waste which increase the exposure of all individuals in communities 
to vector-borne and zoonotic diseases (Thomson et al., 2019).   
5.2. Age at first vaccination and systematic puppy vaccination strategy  
 Assuming that a single vaccination at 3 months protects the animal for at least 3, the 
outcomes of vaccination compartmental models showed that the implementation of systematic 
vaccination of puppies at weaning seems to be a more efficient and appropriate rabies 
vaccination strategy for rabies control in resource-poor and endemic countries, despite high 
turnover rates. Three months of age is just an average. Puppies can be successfully vaccinated 
before they reach the age of 3 months as found in the present study, despite the persistence of 
controversies about the efficacy of rabies vaccine in puppies below 3 months of age. 
 Indeed, rabies vaccine manufactures advice not to vaccinate puppies below 3 months 
of age assuming that they have an immature immune system or that their immune response to 
rabies vaccine may be inhibited by maternal antibodies (Barrat et al., 2001, Morters et al., 
2015). In addition, puppies less than 3 months old are less mobile and present less chance to 
be bitten by a rabid dog (Minyoo et al., 2015, Muthiania et al., 2015, Arief et al.2017). As a 
consequence, puppies below 3 months of age are excluded from rabies vaccination program. 
In contrast, the World Health Organization recommends the inclusion of this category of dogs 
in vaccination program, especially in rabies endemic countries (WHO, 2013). 
 This contraction is indeed nourished by conflicting evidence that can be found in 
published studies. Précausta et al. (1985) showed in a serological study that in presence of 
maternal antibodies, the production of anti-rabies antibodies was inhibited in puppies 




(1990), found that the serological response of puppies (4-12 weeks) to vaccination with live 
vaccine was different whether puppies were from rabies vaccinated-or unvaccinated bitches. 
The antibody production was strong and earlier (from 4 weeks of age) in puppies from 
unvaccinated bitches, whereas it was delayed and strong only at 10 weeks in puppies from 
vaccinated bitches, although the fact that maternal antibodies decrease substantially from 6 
weeks of age. In contrast, other serological studies showed the opposite and suggest that the 
inactivated rabies vaccine was effective in puppies aged from 10 days to 3 months in the 
presence or absence of maternally derived antibodies (Barat et al., 2001; Morters et al., 2015; 
Yangchen et al., 2019). Our own results (Fig 3.5) demonstrated that the rabies vaccine was 
effective in 96% (23/24) of puppies, although the presence of antirabies antibodies which 
could either originate from their mother or from previous vaccination that was not reported to 
inestigators. In addition, the only puppy which failed to seroconvert had no detectable anti-
rabies antibody titer (≤0.18 IU/ml) before vaccination, contrasting the assumption of 
interfering maternal antibodies. Finally, a challenge study of puppies aged of 2 weeks (14 
days showed that, although vaccinated with an inactivated vaccine in presence of high levels 
of maternal antibodies that inhibited the antibody production, all puppies survived when 
challenged 4 months later with a dose of field rabies virus that killed all unvaccinated controls 
(Chappuis, 1998). 
 The successful response to vaccination in puppies from vaccinated-bitches could be 
explained by the level of maternal antibodies and the type of immunity response triggered 
upon vaccination. Indeed, except a little IgG titer (5-10%) that can be transferred 
transplacentally from mother to offspring, the colostrum is the main route by which maternal 
antibodies are transferred to puppies. Thus, the level of circulating maternal antibodies in 
puppies depends on the systemic immunity of the bitch and the quantity of ingested colostrum 
by each puppy (Chappuis, 1998). Accordingly, puppies from vaccinated-bitches may not have 
sufficient maternal antibodies as reported in Sri Lanka (Pimburage et al., 2017) or conversely, 
they may have high level of maternal antibodies which can inhibit postvaccinal production of 
antibodies. One of the assumptions that emerged from the study conducted in humans on 
determinants of infant responses to vaccines in the presence of maternal antibodies carried out 
by Siegrist et al.(1998), was that the B cells response was inhibited particularly when the 
vaccine used in infant contained the same antigen (immunodominant B-cell epitopes) as the 
vaccine used for immunization of his mother. However, the specific T cells response was not 




responses which, even in absence of antibody responses, could eventually contribute to 
protection in case of infection. Yet, it was shown that the rabies vaccine is T-cell dependent 
(Turner, 1976; Mifune et al., 1981; Overduin et al., 2019), providing explanation of why 
puppies with high level of maternal antibodies and inadequate postvaccinal antibody 
production survived to challenge several months later as reported by Chappuis (1998).  
 Above serological and challenge studies provide two evidences: (i) the satisfactory 
immunocompetence of puppies within their first days of life, and (ii) the efficacy of rabies 
vaccine in puppies of below 3 months of age in the presence or absence of maternal 
antibodies. These evidences strongly suggest that puppies from vaccinated or unvaccinated 
bitches against rabies may be vaccinated from 2 weeks of age. Furthermore, if the majority of 
bitches are not vaccinated against rabies, the risk of inhibition of the serological response of 
vaccine in puppies below 3 months of age is negligible. For more realistic practice, we 
suggest the vaccination of puppies at weaning (≥8 weeks of age). In addition, as a reminder 
(see discussion section of Chapter 3) it was suggested that a single vaccine may provide a 
lifetime protection against rabies given that the duration of immunity provided by rabies 
vaccine (≥3 years) (Lakshmanan et al.,2006 ; Schultz, 2006 ; Roth and Spickler, 2010;  
Malerczyk et al., 2007; Moore et al.,2015; Day et al.,2016) was longer than the life 
expectancy (≤3 years) of dogs in poor settings (Jibat et al.,2015). In these poor and high risk 
settings, due to high turnover rate (36%) as the direct results of high birth rate (45%) and high 
disappearance rate (40%), close to 50% of dog population is made up of puppies and juvenile 
dogs. When puppies are excluded from vaccination program, they are responsible for the 
rapid decrease of coverage, supporting the recommendation of annual mass vaccination 
strategy for prevention of rabies outbreaks (Fig. 3.7). Yet, when puppies are systematically 
vaccinated at weaning, the vaccination coverage does not fall, eliminating the need of 
logistically difficult and costly annual mass vaccination campaign strategy (Fig. 3.8).  This 
result confirmed epidemiological and economic reasons of including puppies in vaccination 
program as suggested by some studies (Kaare et al., 2009; WHO, 2013). 
5.3. How to control rabies in resource-poor settings 
 The study found that country such as DRC has a rabies network made up of medical 
and veterinary structures, despite inadequate collaboration between both sectors. This rabies 




implementation of an efficient and sustainable rabies control program. Therefore, approaches 
for improving rabies control program are discussed below. 
 Dog-mediated human rabies mainly affects poor areas of Africa and Asia where 
people are less educated and where access to prompt and appropriate post-exposure  
prophylaxis (PEP) is limited or nonexistent (Knobel et al., 2007; Global Alliance for Rabies 
Control, 2015). Yet, rabies can be eliminated at its source by vaccinating dogs, in 
combination with dog population management , bite management, raising public awareness 
and improved access to prompt PEP (WHO, 1987; Global Alliance for Rabies Control, 2015; 
Wallace et al., 2017). In addition, economic studies indicate that vaccination of dogs is the 
most cost-effective approach for preventing rabies in humans (Bögel and Meslin, 1990). 
Although dog-mediated rabies was successfully eliminated in some parts of the world such as 
Western Europe , America and the Caribbean Islands (WHO, 2013; Taylor and Nel, 2015), 
rabies remains endemic in several countries of Africa and Asia (Global Alliance for Rabies 
Control, 2015). Most of dog-rabies endemic countries are still facing barriers for rabies 
control, which are related to limited understanding of the local epidemiology, logistic and 
operational challenges, lack of resources, and competing priorities with other diseases 
(Wallace et al., 2017). 
 It is therefore important to propose an integrated, efficient and sustainable theoretical 
rabies control program .To achieve this goal, we used three approaches: (i) stratification of 
risk zones, (ii) focusing vaccination on young dogs and (iii) community engagement and One 
Health approach.  
 The first stage of reduction of resource needed for rabies vaccination program was the 
stratification of risk zones of rabies transmission for optimization of resource allocation by 
initially targeting high risk zone (Fahrion et al., 2017). The practical outcomes will be the 
reduction of the number of dogs that need vaccination, the number of vaccine doses and 
vaccination certificate, the human and logistic resources needed for massive vaccination of 
dog population.  
 The second stage is the systematic vaccination of puppies at weaning (≥8 weeks of 
age). Theoretically, this strategy may further reduce material, human and logistic resource 
needed for an effective rabies vaccination program. Indeed; with this strategy, the target 
population (weaned puppies) for vaccination is very low (≤10% of dog population). In 




against rabies as discussed above. In contrast, with the annual mass vaccination campaign 
strategy, all accessible dogs are vaccinated irrespective of their prior vaccination status, 
resulting in many dogs being revaccinated every year and the high needs for resources. Yet, 
the revaccination recommendation is not justified given the duration of immunity provided by 
the vaccine (≥3 years) (Lakshmanan et al.,2006 ; Schultz, 2006 ; Roth and Spickler, 2010;  
Malerczyk et al., 2007; Moore et al.,2015; Day et al.,2016).  
 The third stage for improving the efficiency of rabies control program includes the 
community engagement and the intersectoral collaboration. The community engagement is 
referring to the involvement of community volunteers in conducting household dog ecology 
surveys, raising awareness about vaccination for increasing dog accessibility, dog bite 
prevention education, early warning of dead or killed suspect dogs, human bite exposures and 
suspect rabies cases. These community volunteers called “relais communautaires” are actively 
used in the community-based surveillance in medical health sector since 2005 in DRC 
(Mawazo, 2013). Their role could be expanded to above-mentioned rabies activities involving 
a strong collaboration between medical and veterinary sectors. In addition, the setting up of an 
integrated bite case management (IBCM) approach as a result of improving communication 
across medical health and veterinary workers, is crucial for prevention of human rabies deaths 
through the appropriate use of post-exposure prophylaxis (PEP) and money-saving by 
avoiding the overuse of costly PEP (350 USD). For purely epidemiologic reasons, data-
sharing between health facilities and veterinary structures is useful for assessing the impact of 
implemented dog vaccination strategy. In addition, available cold chain in health facilities 
(PATH, 2016), may also help for storage of veterinary rabies vaccine given poor veterinary 
infrastructures (Ministère de Pêche et Elevage, 2017). These local resources need the legal 
collaborative framework for their mobilization.  
 The lesson to be drawn from this section is that even in resource-poor countries; 
human rabies incidence may be reduced by vaccinating dogs in high risk zones and 
appropriate use of costly post-exposure prophylaxis through a strong collaboration mainly 
between medical and veterinary sectors at local level and community engagement. DRC is 
lucky given that the country has large network of health facilities and veterinary structures, 
despite that the capacity building is necessary mainly for efficient use of veterinary 
infrastructures (Fig. 5.1.). Finally, the study provides to policy makers financially sustainable 



















































6.1. Conclusion  
 This thesis aimed at assessing factors of dog rabies maintenance and proposing an 
integrated, efficient and sustainable theoretical rabies control program in DRC. 
 The understanding of local risk factors is useful for designing the most appropriate 
rabies control program. Our study has contributed substantially to understand the risk factors 
of rabies transmission in urban setting. It highlighted that poor dog-keeping practices and low 
vaccination coverage are the main factors of rabies transmission in dog population. Both risk 
factors are strongly influenced by socioeconomic status of households, and consequently help 
to define different risk zones within urban settings. These are low, moderate and high risk 
zones. Usually high risk zones corresponded to poor settings. In these settings, the vaccination 
of dogs and the appropriate use of post-exposure prophylaxis are short-term actions for rabies 
control. The dog management program may be challenging by the poor dog ownership and 
especially the absence of physical barrier for dog roaming restriction. Accordingly, three 
approaches were proposed for setting up an integrated, efficient and sustainable rabies control 
program. The prioritization of high risk zones for rabies actions such as mass vaccination was 
assumed as the first way of improving the efficiency of rabies program through reduction of 
resource needs. The systematic and single vaccination of puppies at weaning (≥8 weeks of 
age) was assumed as the second way of significant reduction of need for resources. In a 
complementary way, the community engagement and the strong collaboration between mainly 
health facilities and veterinary structures, may improve the dog accessibility and therefore 
rapid increase of vaccination coverage, monetary saving through appropriate use of costly 
post-exposure prophylaxis. Finally, this study provides to policy makers financially 
sustainable and technically efficient alternatives for rabies control in resource-poor settings.  
6.2. Perspectives 
 Our research hypothesized the fact that dog-mediated rabies may be controlled in 
resource-poor settings or countries through setting up an integrated, efficient and sustainable 





Table 6.1. Perspective field studies  
N
0
 Studies  (referring to 4 specific objectives) Key findings Perspectives 
1 Risk factors of rabies maintenance in dog 
population  
 Poor dog-keeping practices and low 
vaccination coverage  are the main risk 
factors if rabies maintenance in dog 
population  
 Development of a tool for local stratification 
of rabies risk levels     
 Use of geographical  tools for urbanization 
classification and stratification of risk zones 
at area-scale 
 Role of wildlife in rabies maintenance 
  Molecular characterization of rabies viruses 
which are circulating in  animals  
2. Rabies vaccination scheme against rabies   Assumption that a single dose of vaccine 
provides a lifetime protection 
 Systematic vaccination of puppies at 
weaning prevents the decline in the 
proportion of vaccinated subpopulation. 
 Serological follow-up of dogs vaccinated at 
weaning in field conditions  
 Longitudinal follow-up of dog population 
dynamics during at least 3 years  
3. Intersectoral collaboration in the rabies 
management  
 Rabies network is made up mainly of 
medical and veterinary institutions 
 Non-involvement of wildlife sector in rabies 
management  
 Inadequate collaboration between  medical 
and veterinary sectors in relation with rabies 
management  
 
 Further institutional analysis study with a 
wider range of stakeholders and respondents 
 Efficiency use of available veterinary 
resources   
 Acceptability of the integrated approach for 
rabies prevention and control  by the 
medical, veterinary and wildlife workers and 
the community 
4 Rabies control program for resource-poor 
and endemic countries  
 Setting up of an integrated, efficient and 
sustainable rabies control framework   
 Cost-effectiveness comparison of different 
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Appendices of Chapter 2 
 
Figure S2.1.  Factors associated to free roaming dogs in surveyed areas in Kinshasa: residency 
without fence or wall, attractive sites such as open market (b) and public dumps (c,d)   
Table S1.1. Owners report ways for getting rid of their dogs in case of behavioral disorder, sickness or 
old age 
Ways for getting ride  Number of 
answers 
Percentage (%) 
To sell the dog to dog meat consumers 174 35 
To abandon  the dog in nature away from the residency area 42 8 
To send the dog to village for hunting use  36 7 








Appendices of Chapter 3 
 
Figure S3.1. Boxplot showing overall patterns of temperature recorded in refrigerators in veterinary 
drugstores in Kinshasa using recording thermometer (Extech RH
®
) over periods of 2 days. 




Table S3.1. Anti-rabies antibody of puppies (2-3 months) before (D0) and after (D30) rabies 
vaccination 
Dog Age at vaccination 
(weeks) 
Titer (IU/ml) at day 
0 (D0)  
Titer (IU/ml) at 
day30 (D30) 
Effectiveness of 
vaccine in puppy 
1 11-12 < 0.18 10 Yes 
2 11-12 < 0.18 10 Yes 
3 10-12 < 0.18 10 Yes 
4 10 < 0.18 10 Yes 
5 9 < 0.18 0.37 No 
6 11-12 < 0.18 7.54 Yes 
7 12 < 0.18 4.75 Yes 
8 11 < 0.18 10 Yes 
9 10 0.19 1.64 Yes 
10 12 0.25 10 Yes 
11 10-12 0.35 7.01 Yes 
12 11-12 0.5 4.46 Yes 
13 11-12 0.58 10 Yes 
14 10-12 0.62 4.71 Yes 
15 10-12 0.88 4.97 Yes 
16 12 1.23 10 Yes 
17 8 1.64 10 Yes 
18 10-12 1.64 3.44 Yes 
19 8 1.85 10 Yes 
20 8 1.85 3.99 Yes 
21 11-12 2.51 10 Yes 




23 8-9 3.99 6.01 Yes 
24 10 4.71 5.13 Yes 
           Abbreviation: IU International Unit; effectiveness criteria:  D30 titer ≥0.5 if the D0 titer was < 0.5 or absolute 
increase of D30 titer if D0 titer ≥ 0.5 




 Time span (years) 
since last and booster 
vaccination   
Titer (IU/ml) at D0 
(day0) 




1 1.2 0.4 5.5 Yes 
2 1.3 1.71 2.26 Yes 
3 1.3 0.55 10 Yes 
4 1.3 0.18 5.52 Yes 
5 1.3 0.15 0.61 Yes 
6 1.3 0.55 10 Yes 
7 1.3 4.04 5.31 Yes 
8 1.3 10 10 Yes 
9 1.3 10 10 Yes 
10 1.5 1.71 4.45 Yes 
11 1.5 1.95 10 Yes 
12 1.5 0.78 0.87 Yes 
13 1.5 2.06 4.96 Yes 
14 1.5 0.18 0.17 No 
15 1.5 1.61 10.32 Yes 
16 1.6 0.18 0.39 No 
17 1.8 0.52 1.25 Yes 
18 1.8 10 10 Yes 
19 1.9 1.09 10 Yes 
20 2 1.25 5.86 Yes 
21 2 4.55 10 Yes 
22 2 0.51 3.81 Yes 
23 2 0.48 2.28 Yes 
24 2 0.51 3.67 Yes 
25 2 0.31 1.55 Yes 
26 2 3.12 7.04 Yes 
27 2 0.32 1.84 Yes 
28 2 0.31 1.65 Yes 
29 2 5.18 10 Yes 
30 2 1.46 5.4 Yes 
31 2 1.73 1.37 Yes 
32 2.5 10 10 Yes 
33 2.5 2.15 10 Yes 
34 2.5 5.68 10 Yes 
35 2.5 1.48 10 Yes 




37 3 7.04 10 Yes 
38 3 0.53 1.52 Yes 
39 3 0.53 3.06 Yes 
40 3 1.19 6.46 Yes 
41 3 2.89 10 Yes 
42 3 0.45 1.71 Yes 
43 3 0.57 1.94 Yes 
44 3.5 0.35 1.17 Yes 
45 4.5 0.24 1.77 Yes 
46 4.5 1.34 10 Yes 
47 7.5 1.11 1.57 Yes 
Abbreviation: IU International Unit; adequate anamnestic response:  D8 titer ≥0.5 if the D0 titer was < 0.5 or 
absolute increase of D8 titer if D0 titer ≥ 0.5 
Appendices of chapter 4 
S4.1.Check-list of key informant opinions about One Health approach 
implementation in rabies control in DRC 
The main goal of our study is to collect your opinions on the One Health approach implementation in 
rabies control in DRC.  I want to have a semi-structured interview with you. Any information 
collected from this interview will be protected and the results will be used for rabies control. Please, 
keep in mind that you are free to opt out of the survey. Are you willing to participate to this survey? 
      
Date       No. 
  Institution   
 
  
Key informant     Key informant   
Position     Position   
Phone number     Phone number   
E-mail     E-mail   
          
The institution role in relation with rabies      
  
   
  
  
   
  
  
   
  
  
   
  
    
  
Rabies control actions taken     
  
   
  
  
   
  
  
   
  
  
   
  





 Understanding of One health  (OH) approach        
    
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
Involvement in OH approach and challenges encountered   
          
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
    
  
          





   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
          
Proposed  strategies for making the OH approach a reality in the rabies management  
          
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  




Expectations from implementation of OH approach  
          
  
   
  
  
   
  
  
   
  
  
   
  
  
   
  
    
  
 


















Figure S4.1. Rabies data flow in DRC. (a) Veterinary health surveillance system ( Kazadi, 2014; Ministère Pêche et Elevage, 2017) and  (b) Medical health 






Figure S4. 2.  (a) trend of  suspect samples received for rabies testing  from 1980 to 2017 at the 
Central Veterinary Laboratory of Kinshasa and (b) sample senders. 
 
 
 
 
 
 
 
 
 
